syndrome	score	normalized_score
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.22014709200000002	100.0
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.20194415400000001	91.73146561481721
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.20054555400000001	91.09616310534776
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	90.84834970247982
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.2	90.84834970247982
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.069873	31.739233693806867
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.059415004	26.988775304831186
ROTHMUND-THOMSON SYNDROME	0.054742104	24.866149038207595
ACROMELIC FRONTONASAL DYSPLASIA	0.054742104	24.866149038207595
NAIL-PATELLA SYNDROME	0.05419655	24.618335635339665
9Q33.3Q34.11 MICRODELETION SYNDROME	0.0540302	24.542772520474625
PRIMARY PULMONARY HYPOPLASIA	0.0540302	24.542772520474625
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.0540302	24.542772520474625
SCHOLTE SYNDROME; SHLTS	0.053593138	24.3442407133863
SAY-BARBER-MILLER SYNDROME	0.053177154	24.155283413873118
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.053177154	24.155283413873118
PATELLA APLASIA-HYPOPLASIA	0.0526316	23.907470011005184
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.0526316	23.907470011005184
ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION	0.0526316	23.907470011005184
17Q23.1Q23.2 MICRODELETION SYNDROME	0.0526316	23.907470011005184
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES	0.0526316	23.907470011005184
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.0526316	23.907470011005184
FRANK-TER HAAR SYNDROME; FTHS	0.04356624	19.78960503371082
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.039571150000000006	17.974868366646426
SECKEL SYNDROME 2; SCKL2	0.036982940000000006	16.799195330729148
CHROMOSOME 9P DELETION SYNDROME	0.036238992	16.46126309040684
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.035818234	16.270137240786262
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.035277454	16.02449238802573
TETRASOMY 5P	0.035277454	16.02449238802573
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.034898250000000006	15.852242100022835
NEONATAL MARFAN SYNDROME	0.0347319	15.776678985157796
TRISOMY 8P	0.034294838	15.578147178069468
STUVE-WIEDEMANN SYNDROME	0.033345478	15.146908231701737
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.0333333	15.141376475688356
CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES	0.0333333	15.141376475688356
IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION	0.0333333	15.141376475688356
CONGENITAL TRICUSPID STENOSIS	0.0333333	15.141376475688356
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.0333333	15.141376475688356
CONGENITAL AORTIC VALVE STENOSIS	0.0333333	15.141376475688356
EISENMENGER SYNDROME	0.0333333	15.141376475688356
AORTO-VENTRICULAR TUNNEL	0.0333333	15.141376475688356
RING CHROMOSOME 7 SYNDROME	0.0333333	15.141376475688356
PARTIAL ATRIOVENTRICULAR CANAL	0.0333333	15.141376475688356
FAMILIAL ATRIAL MYXOMA	0.0333333	15.141376475688356
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.0333333	15.141376475688356
CARCINOID SYNDROME	0.0333333	15.141376475688356
PERIPARTUM CARDIOMYOPATHY	0.0333333	15.141376475688356
ANEURYSM OF SINUS OF VALSALVA	0.0333333	15.141376475688356
DOUBLE OUTLET RIGHT VENTRICLE	0.0333333	15.141376475688356
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.0333333	15.141376475688356
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.0333333	15.141376475688356
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	0.0333333	15.141376475688356
PULMONARY ARTERIOVENOUS MALFORMATION	0.0333333	15.141376475688356
FAMILIAL BICUSPID AORTIC VALVE	0.0333333	15.141376475688356
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.031078559999999998	14.117179435647506
KNIEST-LIKE DYSPLASIA, LETHAL	0.031078559999999998	14.117179435647506
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.028550452	12.968807237299323
ZELLWEGER SYNDROME	0.025644760000000003	11.648920622580833
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.025423404	11.548371486097123
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.024349950000000002	11.060763864189493
KAGAMI-OGATA SYNDROME	0.024292092	11.034482345104063
RESTRICTIVE DERMOPATHY, LETHAL	0.0241836	10.985200749324456
HOLOPROSENCEPHALY	0.024024804	10.913068976627681
DISTAL MONOSOMY 15Q	0.023858454	10.837505861762644
RING CHROMOSOME 14 SYNDROME	0.023796732	10.809469152560961
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.023387104	10.623399013601324
YUNIS-VARON SYNDROME	0.023220754	10.547835898736285
KNIEST DYSPLASIA	0.02284155	10.37558561073339
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.022783692	10.34930409164796
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.022783692	10.34930409164796
KYPHOMELIC DYSPLASIA	0.0226752	10.300022495868353
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.0226752	10.300022495868353
LETHAL KNIEST-LIKE DYSPLASIA	0.0226752	10.300022495868353
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.0226752	10.300022495868353
48,XXYY SYNDROME	0.022459854	10.202203352293202
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.022398132	10.174166643091521
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.022238138	10.101490688780027
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.022238138	10.101490688780027
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.022238138	10.101490688780027
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.022238138	10.101490688780027
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.022238138	10.101490688780027
FAMILIAL LAMBDOID SYNOSTOSIS	0.0219143	9.954389949425268
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.021852578	9.926353240223586
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.021852578	9.926353240223586
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.021852578	9.926353240223586
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.021852578	9.926353240223586
SAUL-WILSON SYNDROME; SWILS	0.021822154	9.912533389266844
THANATOPHORIC DYSPLASIA, TYPE I	0.021822154	9.912533389266844
GRACILE BONE DYSPLASIA; GCLEB	0.021822154	9.912533389266844
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.021822154	9.912533389266844
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.021436594	9.737395940710405
THANATOPHORIC DYSPLASIA, TYPE II	0.0212766	9.66471998639891
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.0212766	9.66471998639891
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.0212766	9.66471998639891
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.0212766	9.66471998639891
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0212766	9.66471998639891
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.0212766	9.66471998639891
XYLT1-CDG	0.0212766	9.66471998639891
HYPOCHONDROPLASIA	0.0212766	9.66471998639891
DYSOSTEOSCLEROSIS	0.0212766	9.66471998639891
MELNICK-NEEDLES SYNDROME	0.0212766	9.66471998639891
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.0212766	9.66471998639891
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.0212766	9.66471998639891
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.0212766	9.66471998639891
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.0212766	9.66471998639891
JACOBSEN SYNDROME	0.021166488	9.614702518986714
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.020750504	9.425745219473532
VAN MALDERGEM SYNDROME 2; VMLDS2	0.020557768	9.338196481832247
VAN MALDERGEM SYNDROME 1; VMLDS1	0.020557768	9.338196481832247
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.02020495	9.177931816605598
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.020147092000000002	9.15165029752017
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.020147092000000002	9.15165029752017
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.020147092000000002	9.15165029752017
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.019975434	9.073676067454027
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.019601538	8.903836894652235
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.019601538	8.903836894652235
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.019601538	8.903836894652235
ADENYLOSUCCINATE LYASE DEFICIENCY	0.019601538	8.903836894652235
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.019351904	8.79044271000409
MAN1B1-CDG	0.019185554	8.714879595139054
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.019185554	8.714879595139054
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.019185554	8.714879595139054
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.018852282	8.563493539128828
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.018852282	8.563493539128828
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.018748492000000002	8.516347788050728
ANGELMAN SYNDROME	0.018748492000000002	8.516347788050728
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.01864	8.467066192271119
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.01864	8.467066192271119
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.01864	8.467066192271119
DUBOWITZ SYNDROME	0.018306728	8.315680136260896
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.018306728	8.315680136260896
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.018202938000000002	8.268534385182793
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.018202938000000002	8.268534385182793
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.018202938000000002	8.268534385182793
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.018202938000000002	8.268534385182793
TORIELLO-LACASSIE-DROSTE SYNDROME	0.01803128	8.190560155116652
MYHRE SYNDROME	0.017890744	8.126722836747714
FRONTOOCULAR SYNDROME	0.017890744	8.126722836747714
MARDEN-WALKER SYNDROME	0.017890744	8.126722836747714
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.017890744	8.126722836747714
HOLOPROSENCEPHALY 7	0.017786954	8.079577085669612
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.017786954	8.079577085669612
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.01734519	7.87890943387978
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.017287332	7.85262791479435
CHROMOSOME 16Q22 DELETION SYNDROME	0.017287332	7.85262791479435
DISTAL 17P13.1 MICRODELETION SYNDROME	0.0172414	7.831763682801679
OCULOCEREBRORENAL SYNDROME OF LOWE	0.0172414	7.831763682801679
PITT-HOPKINS-LIKE SYNDROME	0.0172414	7.831763682801679
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.0172414	7.831763682801679
BUSCHKE-OLLENDORFF SYNDROME	0.0172414	7.831763682801679
HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	0.0172414	7.831763682801679
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0172414	7.831763682801679
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.0172414	7.831763682801679
FRONTONASAL DYSPLASIA	0.0172414	7.831763682801679
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.0172414	7.831763682801679
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.0172414	7.831763682801679
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.0172414	7.831763682801679
OPSISMODYSPLASIA	0.0172414	7.831763682801679
SCHIZOPHRENIA 1; SCZD1	0.0172414	7.831763682801679
CRANIOSYNOSTOSIS 4; CRS4	0.0172414	7.831763682801679
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.016908128	7.680377626791454
CAMPOMELIC DYSPLASIA	0.016741778	7.604814511926415
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.016741778	7.604814511926415
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.016741778	7.604814511926415
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.016741778	7.604814511926415
DUANE RETRACTION SYNDROME	0.016492144	7.491420327278273
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.016325794	7.4158572124132345
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.016325794	7.4158572124132345
DIGEORGE SYNDROME; DGS	0.016325794	7.4158572124132345
HUNTER-MACDONALD SYNDROME	0.01594659	7.243606924410338
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.01594659	7.243606924410338
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.01594659	7.243606924410338
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.015888732	7.217325405324908
MEIER-GORLIN SYNDROME 1; MGORS1	0.01578024	7.168043809545302
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.01578024	7.168043809545302
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.01578024	7.168043809545302
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.01578024	7.168043809545302
113470 BRACHYMESOMELIA-RENAL SYNDROME	0.01578024	7.168043809545302
FEINGOLD SYNDROME 1; FGLDS1	0.01578024	7.168043809545302
CHROMOSOME 18Q DELETION SYNDROME	0.015343177999999999	6.969512002456975
%300712 CRANIOFACIOSKELETAL SYNDROME	0.014927194000000001	6.780554702943793
ADAMS-OLIVER SYNDROME 3; AOS3	0.014927194000000001	6.780554702943793
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.014927194000000001	6.780554702943793
ARTERIAL TORTUOSITY SYNDROME	0.014927194000000001	6.780554702943793
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.014927194000000001	6.780554702943793
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.01475698	6.703236397962503
LERI PLEONOSTEOSIS	0.014381640000000001	6.53274130007586
ZECHI-CEIDE SYNDROME	0.014381640000000001	6.53274130007586
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.014381640000000001	6.53274130007586
ECTRODACTYLY OF LOWER LIMBS, CONGENITAL HEART DEFECT, AND MICROGNATHIA	0.014381640000000001	6.53274130007586
OCULODENTODIGITAL DYSPLASIA; ODDD	0.014381640000000001	6.53274130007586
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.014381640000000001	6.53274130007586
%608572 BURN-MCKEOWN SYNDROME	0.014381640000000001	6.53274130007586
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.014179382	6.44086727250524
OROFACIODIGITAL SYNDROME XVI; OFD16	0.014179382	6.44086727250524
SIFRIM-HITZ-WEISS SYNDROME	0.013633828	6.193053869637306
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.013621814	6.187596609270677
KAGAMI-OGATA SYNDROME	0.013621814	6.187596609270677
2Q31.1 MICRODELETION SYNDROME	0.013217844000000001	6.0040965701241245
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.013217844000000001	6.0040965701241245
EMANUEL SYNDROME	0.012874002	5.847909178832124
WIEDEMANN-STEINER SYNDROME	0.012672290000000001	5.75628316725619
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.012614432	5.73000164817076
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.012614432	5.73000164817076
TARP SYNDROME; TARPS	0.012614432	5.73000164817076
CINCA SYNDROME	0.012598554000000001	5.72278919768788
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.012328448	5.60009577596419
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.012328448	5.60009577596419
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.012068878	5.482188245302826
FONTAINE PROGEROID SYNDROME; FPS	0.012068878	5.482188245302826
TYSHCHENKO SYNDROME	0.011912464000000001	5.411138476451009
COSTELLO SYNDROME; CSTLO	0.011912464000000001	5.411138476451009
FANCONI ANEMIA	0.011819244000000001	5.368794060654683
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.011819244000000001	5.368794060654683
ZECHI-CEIDE SYNDROME	0.011652894	5.293230945789644
TOLUENE EMBRYOPATHY	0.011652894	5.293230945789644
SCHAAF-YANG SYNDROME; SHFYNG	0.011652894	5.293230945789644
INFANTILE SIALIC ACID STORAGE DISEASE	0.011475402	5.212606669362682
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.011309052	5.1370435544976445
MCDONOUGH SYNDROME	0.011273690000000001	5.120980657786749
ACRO-RENAL-OCULAR SYNDROME	0.011273690000000001	5.120980657786749
CHROMOSOME 1P36 DELETION SYNDROME	0.011228232000000001	5.100331736382873
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.011215832	5.094699138701318
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.011215832	5.094699138701318
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.011215832	5.094699138701318
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.011215832	5.094699138701318
TARP SYNDROME	0.011215832	5.094699138701318
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.011215832	5.094699138701318
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.011215832	5.094699138701318
IMMUNODEFICIENCY 49; IMD49	0.011215832	5.094699138701318
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.01110734	5.045417542921712
21Q22.11Q22.12 MICRODELETION SYNDROME	0.01110734	5.045417542921712
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.01110734	5.045417542921712
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.01110734	5.045417542921712
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.01110734	5.045417542921712
RESTRICTIVE DERMOPATHY	0.01110734	5.045417542921712
16P12.1P12.3 TRIPLICATION SYNDROME	0.01110734	5.045417542921712
YUNIS-VARON SYNDROME	0.010763498	4.889230151629711
JACOBSEN SYNDROME	0.010513864000000001	4.7758359669815675
CARDIOFACIOCUTANEOUS SYNDROME	0.010513864000000001	4.7758359669815675
VASCULAR EHLERS-DANLOS SYNDROME	0.010513864000000001	4.7758359669815675
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.010347514	4.700272852116529
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.010347514	4.700272852116529
DISTAL MONOSOMY 10Q	0.010347514	4.700272852116529
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.010254294	4.657928436320204
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.010254294	4.657928436320204
PETERS PLUS SYNDROME	0.010254294	4.657928436320204
6Q TERMINAL DELETION SYNDROME	0.010254294	4.657928436320204
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.010254294	4.657928436320204
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.009968310000000001	4.528022564113634
CORNELIA DE LANGE SYNDROME	0.009968310000000001	4.528022564113634
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.009910452	4.5017410450282025
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.009910452	4.5017410450282025
ROIFMAN SYNDROME; RFMN	0.009910452	4.5017410450282025
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.009910452	4.5017410450282025
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.009910452	4.5017410450282025
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.009910452	4.5017410450282025
3MC SYNDROME 1	0.009887489999999999	4.49131074599886
3MC SYNDROME 3	0.009887489999999999	4.49131074599886
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00980196	4.452459449248596
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00980196	4.452459449248596
GAUCHER DISEASE, PERINATAL LETHAL	0.00980196	4.452459449248596
GMS SYNDROME	0.00980196	4.452459449248596
INTERMEDIATE NEMALINE MYOPATHY	0.00980196	4.452459449248596
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00980196	4.452459449248596
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00980196	4.452459449248596
FEINGOLD SYNDROME	0.00970874	4.41011503345227
FRONTONASAL DYSPLASIA 2; FND2	0.00970874	4.41011503345227
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00970874	4.41011503345227
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00970874	4.41011503345227
PELVIS-SHOULDER DYSPLASIA	0.00970874	4.41011503345227
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00970874	4.41011503345227
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00970874	4.41011503345227
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00970874	4.41011503345227
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.00970874	4.41011503345227
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.009364898	4.25392764216027
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.009364898	4.25392764216027
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.009364898	4.25392764216027
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.009364898	4.25392764216027
NEMALINE MYOPATHY 10	0.009364898	4.25392764216027
TEMPLE SYNDROME	0.009364898	4.25392764216027
2P15P16.1 MICRODELETION SYNDROME	0.009143542000000001	4.153378505676559
PEDIATRIC-ONSET GRAVES DISEASE	0.008948914	4.064970342647088
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.008948914	4.064970342647088
GALLOWAY-MOWAT SYNDROME	0.008948914	4.064970342647088
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.008948914	4.064970342647088
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.008948914	4.064970342647088
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.008948914	4.064970342647088
FG SYNDROME TYPE 1	0.008948914	4.064970342647088
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.008948914	4.064970342647088
ROBERTS SYNDROME	0.008948914	4.064970342647088
CONGENITAL TOXOPLASMOSIS	0.008948914	4.064970342647088
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.008948914	4.064970342647088
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.008948914	4.064970342647088
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.008948914	4.064970342647088
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.008948914	4.064970342647088
MARDEN-WALKER SYNDROME	0.008597988	3.905565102808626
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.008597988	3.905565102808626
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.008597988	3.905565102808626
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	3.8171569397791547
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	3.8171569397791547
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00840336	3.8171569397791547
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00840336	3.8171569397791547
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	3.8171569397791547
MICROFORM HOLOPROSENCEPHALY	0.00840336	3.8171569397791547
DISTAL MONOSOMY 17Q	0.00840336	3.8171569397791547
VACTERL/VATER ASSOCIATION	0.00840336	3.8171569397791547
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	3.8171569397791547
ADAMS-OLIVER SYNDROME	0.00840336	3.8171569397791547
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	3.8171569397791547
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	3.8171569397791547
TEMPLE SYNDROME	0.00840336	3.8171569397791547
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	3.8171569397791547
HEC SYNDROME	0.00840336	3.8171569397791547
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	3.8171569397791547
PELIZAEUS-MERZBACHER DISEASE	0.00840336	3.8171569397791547
CONGENITAL ANALBUMINEMIA	0.00840336	3.8171569397791547
SILVER-RUSSELL SYNDROME	0.00840336	3.8171569397791547
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	3.8171569397791547
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	3.8171569397791547
HYDROLETHALUS	0.00840336	3.8171569397791547
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00840336	3.8171569397791547
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	3.8171569397791547
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	3.8171569397791547
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	3.8171569397791547
BECKWITH-WIEDEMANN SYNDROME	0.00840336	3.8171569397791547
EBSTEIN MALFORMATION	0.00840336	3.8171569397791547
BRONCHOPULMONARY DYSPLASIA	0.00840336	3.8171569397791547
CONGENITAL ENTEROVIRUS INFECTION	0.00840336	3.8171569397791547
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	3.8171569397791547
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	3.8171569397791547
DIETHYLSTILBESTROL SYNDROME	0.00840336	3.8171569397791547
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00840336	3.8171569397791547
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.00840336	3.8171569397791547
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	3.8171569397791547
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	3.8171569397791547
OMPHALOCELE	0.00840336	3.8171569397791547
SCHISIS ASSOCIATION	0.00840336	3.8171569397791547
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	3.8171569397791547
PEMPHIGOID GESTATIONIS	0.00840336	3.8171569397791547
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.00840336	3.8171569397791547
DIAMOND-BLACKFAN ANEMIA 1	0.00840336	3.8171569397791547
RENAL TUBULAR DYSGENESIS	0.00840336	3.8171569397791547
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	3.8171569397791547
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	3.8171569397791547
FATCO SYNDROME	0.00840336	3.8171569397791547
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	3.8171569397791547
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00840336	3.8171569397791547
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	3.8171569397791547
CLASSICAL EHLERS-DANLOS SYNDROME	0.00840336	3.8171569397791547
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	3.8171569397791547
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	3.8171569397791547
RETINOPATHY OF PREMATURITY	0.00840336	3.8171569397791547
14Q12 MICRODELETION SYNDROME	0.00832254	3.7804451216643824
HARDIKAR SYNDROME	0.00832254	3.7804451216643824
DISTAL TRISOMY 6P	0.008182004	3.7166078032954437
JOUBERT SYNDROME 14	0.008120282	3.6885710940937613
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.007744942	3.5180759962071178
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.007744942	3.5180759962071178
KOOLEN-DE VRIES SYNDROME; KDVS	0.007744942	3.5180759962071178
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.0076364499999999995	3.4687944004275097
3MC SYNDROME	0.0076364499999999995	3.4687944004275097
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.0076364499999999995	3.4687944004275097
8Q21.11 MICRODELETION SYNDROME	0.0076364499999999995	3.4687944004275097
WIEDEMANN-STEINER SYNDROME; WDSTS	0.007578592	3.44251288134208
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.007578592	3.44251288134208
MICROPHTHALMIA, SYNDROMIC 1	0.007574728	3.4407576912258278
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.007199388	3.2702625933391842
OHDO SYNDROME	0.007199388	3.2702625933391842
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.007033038	3.1946994784741465
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.007033038	3.1946994784741465
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.007033038	3.1946994784741465
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.006783404	3.081305293826002
MOSAIC TRISOMY 14	0.006783404	3.081305293826002
KOOLEN-DE VRIES SYNDROME	0.006783404	3.081305293826002
3MC SYNDROME 2	0.006783404	3.081305293826002
COACH SYNDROME	0.0067216820000000005	3.05326858462432
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.0067216820000000005	3.05326858462432
CHROMOSOME 5Q12 DELETION SYNDROME	0.0067216820000000005	3.05326858462432
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.0067216820000000005	3.05326858462432
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.006617054	3.0057421789609644
16P11.2P12.2 MICRODELETION SYNDROME	0.006617054	3.0057421789609644
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.006617054	3.0057421789609644
8Q22.1 MICRODELETION SYNDROME	0.006617054	3.0057421789609644
MONOSOMY 9P	0.006617054	3.0057421789609644
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0065553320000000005	2.9777054697592824
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0065553320000000005	2.9777054697592824
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.0065553320000000005	2.9777054697592824
HEART AND BRAIN MALFORMATION SYNDROME	0.0065553320000000005	2.9777054697592824
ADENYLOSUCCINASE DEFICIENCY	0.0065553320000000005	2.9777054697592824
VICI SYNDROME; VICIS	0.0065553320000000005	2.9777054697592824
RECOMBINANT CHROMOSOME 8 SYNDROME	0.0065553320000000005	2.9777054697592824
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00623785	2.8334918909580686
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00623785	2.8334918909580686
TRISOMY XQ28	0.00623785	2.8334918909580686
DUBOWITZ SYNDROME	0.00623785	2.8334918909580686
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.00623785	2.8334918909580686
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.00623785	2.8334918909580686
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00623785	2.8334918909580686
ASCHER SYNDROME	0.00623785	2.8334918909580686
SCHWARTZ-JAMPEL SYNDROME	0.00623785	2.8334918909580686
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.00623785	2.8334918909580686
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00623785	2.8334918909580686
FRONTOFACIONASAL DYSPLASIA	0.00623785	2.8334918909580686
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.00623785	2.8334918909580686
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.00623785	2.8334918909580686
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00623785	2.8334918909580686
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00623785	2.8334918909580686
DISTAL TRISOMY 15Q	0.00623785	2.8334918909580686
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00623785	2.8334918909580686
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00623785	2.8334918909580686
DISTAL MONOSOMY 3P	0.00623785	2.8334918909580686
LATHOSTEROLOSIS	0.006176128	2.8054551817563866
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.0060715	2.7579287760930313
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.0060715	2.7579287760930313
PELVISCAPULAR DYSPLASIA	0.0060715	2.7579287760930313
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.0060715	2.7579287760930313
ACROOTOOCULAR SYNDROME	0.0060715	2.7579287760930313
HYPERTELORISM AND TETRALOGY OF FALLOT	0.0060715	2.7579287760930313
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0060715	2.7579287760930313
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0060715	2.7579287760930313
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.0060715	2.7579287760930313
FRYNS SYNDROME; FRNS	0.0060715	2.7579287760930313
SECKEL SYNDROME 1; SCKL1	0.0060715	2.7579287760930313
TRISOMY 18-LIKE SYNDROME	0.0060715	2.7579287760930313
SIMOSA CRANIOFACIAL SYNDROME	0.0060715	2.7579287760930313
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.006009778	2.7298920668913493
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.005760144	2.616497882243205
22Q11.2 MICRODUPLICATION SYNDROME	0.005760144	2.616497882243205
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.005634438	2.5593969690047054
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.005634438	2.5593969690047054
WILLIAMS-BEUREN SYNDROME; WBS	0.005634438	2.5593969690047054
ARTERIAL TORTUOSITY SYNDROME	0.005634438	2.5593969690047054
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.005634438	2.5593969690047054
GLYCEROL KINASE DEFICIENCY; GKD	0.005593794	2.5409347673781673
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.005593794	2.5409347673781673
JOUBERT SYNDROME 10	0.005593794	2.5409347673781673
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.005593794	2.5409347673781673
RING CHROMOSOME 12 SYNDROME	0.005593794	2.5409347673781673
49,XXXXY SYNDROME	0.005218454	2.3704396694915233
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.005218454	2.3704396694915233
DISTAL TRISOMY 17Q	0.005218454	2.3704396694915233
8P11.2 DELETION SYNDROME	0.005218454	2.3704396694915233
CHROMOSOME 2Q37 DELETION SYNDROME	0.005218454	2.3704396694915233
48,XXXY SYNDROME	0.005218454	2.3704396694915233
TRISOMY 18	0.005218454	2.3704396694915233
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.005218454	2.3704396694915233
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.005218454	2.3704396694915233
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.005218454	2.3704396694915233
CURRY-JONES SYNDROME	0.005218454	2.3704396694915233
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.005218454	2.3704396694915233
CEREBROFACIOARTICULAR SYNDROME	0.005218454	2.3704396694915233
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.005218454	2.3704396694915233
PSEUDOAMINOPTERIN SYNDROME	0.005218454	2.3704396694915233
HYPOTONIA-CYSTINURIA SYNDROME	0.00521459	2.368684479375271
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00521459	2.368684479375271
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00521459	2.368684479375271
WITTEVEEN-KOLK SYNDROME	0.005156732000000001	2.3424029602898413
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.005156732000000001	2.3424029602898413
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.005156732000000001	2.3424029602898413
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.005156732000000001	2.3424029602898413
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.005156732000000001	2.3424029602898413
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.005156732000000001	2.3424029602898413
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.005156732000000001	2.3424029602898413
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.005156732000000001	2.3424029602898413
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.005156732000000001	2.3424029602898413
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.005156732000000001	2.3424029602898413
KLEEFSTRA SYNDROME 2; KLEFS2	0.005156732000000001	2.3424029602898413
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.005156732000000001	2.3424029602898413
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.005156732000000001	2.3424029602898413
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.005156732000000001	2.3424029602898413
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.005156732000000001	2.3424029602898413
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.005156732000000001	2.3424029602898413
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.005156732000000001	2.3424029602898413
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.005156732000000001	2.3424029602898413
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.005156732000000001	2.3424029602898413
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.005156732000000001	2.3424029602898413
RING CHROMOSOME 22 SYNDROME	0.005156732000000001	2.3424029602898413
SALLA DISEASE	0.005156732000000001	2.3424029602898413
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.005156732000000001	2.3424029602898413
CRI-DU-CHAT SYNDROME	0.00504824	2.2931213645102333
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00504824	2.2931213645102333
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00504824	2.2931213645102333
JUVENILE POLYPOSIS SYNDROME	0.00504824	2.2931213645102333
PFEIFFER-PALM-TELLER SYNDROME	0.0046729	2.1226262666235898
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.0046729	2.1226262666235898
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.0046729	2.1226262666235898
FETAL AKINESIA SYNDROME, X-LINKED	0.0046729	2.1226262666235898
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.0046729	2.1226262666235898
WAARDENBURG SYNDROME, TYPE 1; WS1	0.0046729	2.1226262666235898
VELOCARDIOFACIAL SYNDROME	0.0046729	2.1226262666235898
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0046729	2.1226262666235898
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.0046729	2.1226262666235898
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.0046729	2.1226262666235898
OTOMANDIBULAR SYNDROME	0.0046729	2.1226262666235898
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.0046729	2.1226262666235898
ANOPHTHALMIA PLUS SYNDROME	0.0046729	2.1226262666235898
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.0046729	2.1226262666235898
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0046729	2.1226262666235898
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.0046729	2.1226262666235898
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.0046729	2.1226262666235898
BRADDOCK SYNDROME	0.0046729	2.1226262666235898
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, MKB TYPE	0.0046729	2.1226262666235898
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0046729	2.1226262666235898
TRIOPIA	0.0046729	2.1226262666235898
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.0046729	2.1226262666235898
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.0046729	2.1226262666235898
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.0046729	2.1226262666235898
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.0046729	2.1226262666235898
MENTAL RETARDATION, X-LINKED 92	0.0046729	2.1226262666235898
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.0046729	2.1226262666235898
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.0046729	2.1226262666235898
HEMIFACIAL MICROSOMIA	0.0046729	2.1226262666235898
WILLIAMS SYNDROME	0.0046729	2.1226262666235898
MICROPHTHALMIA WITH LIMB ANOMALIES	0.0046729	2.1226262666235898
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0046729	2.1226262666235898
WARBURG MICRO SYNDROME 3; WARBM3	0.0046729	2.1226262666235898
WAARDENBURG SYNDROME TYPE 3	0.0046729	2.1226262666235898
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.0046729	2.1226262666235898
TRISOMY 4P	0.0046729	2.1226262666235898
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.0046729	2.1226262666235898
SECKEL SYNDROME 5; SCKL5	0.0046729	2.1226262666235898
NON-DISTAL TRISOMY 10Q	0.0046729	2.1226262666235898
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.0046729	2.1226262666235898
RAPADILINO SYNDROME	0.0046729	2.1226262666235898
PFEIFFER-PALM-TELLER SYNDROME	0.0046729	2.1226262666235898
DERMOTRICHIC SYNDROME	0.0046729	2.1226262666235898
TOWNES-BROCKS SYNDROME	0.0046729	2.1226262666235898
OMODYSPLASIA 1; OMOD1	0.0046729	2.1226262666235898
TRISOMY 18P	0.0046729	2.1226262666235898
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.0046729	2.1226262666235898
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.0046729	2.1226262666235898
CLEFT PALATE-LATERAL SYNECHIA SYNDROME	0.0046729	2.1226262666235898
14Q11.2 MICRODELETION SYNDROME	0.0046729	2.1226262666235898
NEONATAL HEMOCHROMATOSIS	0.0046729	2.1226262666235898
3P25.3 MICRODELETION SYNDROME	0.0046729	2.1226262666235898
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.0046729	2.1226262666235898
TRISOMY 20P	0.0046729	2.1226262666235898
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.0046729	2.1226262666235898
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.0046111780000000005	2.0945895574219078
SENGERS SYNDROME	0.0046111780000000005	2.0945895574219078
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.0046111780000000005	2.0945895574219078
ACETYL-COA CARBOXYLASE DEFICIENCY	0.0046111780000000005	2.0945895574219078
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0046111780000000005	2.0945895574219078
CYCLIC VOMITING SYNDROME	0.0046111780000000005	2.0945895574219078
GLYCOGEN STORAGE DISEASE IXC	0.0046111780000000005	2.0945895574219078
RING CHROMOSOME 13 SYNDROME	0.0046111780000000005	2.0945895574219078
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0046111780000000005	2.0945895574219078
ACROCALLOSAL SYNDROME; ACLS	0.0046111780000000005	2.0945895574219078
DUPLICATION/INVERSION 15Q11	0.0046111780000000005	2.0945895574219078
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.0046111780000000005	2.0945895574219078
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0046111780000000005	2.0945895574219078
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0046111780000000005	2.0945895574219078
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0046111780000000005	2.0945895574219078
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.0046111780000000005	2.0945895574219078
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.0046111780000000005	2.0945895574219078
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.0046111780000000005	2.0945895574219078
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0046111780000000005	2.0945895574219078
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.004470642	2.0307522390529695
JOUBERT SYNDROME 1	0.004470642	2.0307522390529695
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.004470642	2.0307522390529695
COHEN-GIBSON SYNDROME; COGIS	0.004470642	2.0307522390529695
HADZISELIMOVIC SYNDROME	0.004470642	2.0307522390529695
WIEACKER-WOLFF SYNDROME	0.004470642	2.0307522390529695
BARAITSER-WINTER SYNDROME 1; BRWS1	0.004470642	2.0307522390529695
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.004470642	2.0307522390529695
SHASHI-PENA SYNDROME; SHAPNS	0.004470642	2.0307522390529695
GOLDBERG-SHPRINTZEN SYNDROME	0.004470642	2.0307522390529695
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.004470642	2.0307522390529695
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.004470642	2.0307522390529695
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.004470642	2.0307522390529695
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.004470642	2.0307522390529695
JOUBERT SYNDROME 35; JBTS35	0.0044706419999999995	2.0307522390529686
NOONAN SYNDROME 11; NS11	0.0044706419999999995	2.0307522390529686
MONOSOMY 13Q34	0.004195194	1.9056322579087257
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.004195194	1.9056322579087257
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.004195194	1.9056322579087257
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.004195194	1.9056322579087257
BIOTINIDASE DEFICIENCY	0.004195194	1.9056322579087257
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.004195194	1.9056322579087257
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.004195194	1.9056322579087257
CLASSIC PHENYLKETONURIA	0.004195194	1.9056322579087257
COG4-CDG	0.004195194	1.9056322579087257
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.004195194	1.9056322579087257
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.004195194	1.9056322579087257
ABLEPHARON MACROSTOMIA SYNDROME	0.004195194	1.9056322579087257
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.004195194	1.9056322579087257
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.004195194	1.9056322579087257
THYROID HEMIAGENESIS	0.004195194	1.9056322579087257
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.004195194	1.9056322579087257
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.004195194	1.9056322579087257
XP21 MICRODELETION SYNDROME	0.004195194	1.9056322579087257
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.004195194	1.9056322579087257
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004195194	1.9056322579087257
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.004195194	1.9056322579087257
GALACTOSEMIA	0.004195194	1.9056322579087257
LIG4 SYNDROME	0.004195194	1.9056322579087257
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.004195194	1.9056322579087257
OCULOECTODERMAL SYNDROME; OES	0.004195194	1.9056322579087257
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.004195194	1.9056322579087257
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.004195194	1.9056322579087257
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.004195194	1.9056322579087257
GALACTOSE EPIMERASE DEFICIENCY	0.004195194	1.9056322579087257
NEPHRONOPHTHISIS 11; NPHP11	0.004195194	1.9056322579087257
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.004195194	1.9056322579087257
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.004195194	1.9056322579087257
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.004195194	1.9056322579087257
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.004195194	1.9056322579087257
OPTIC PATHWAY GLIOMA	0.004195194	1.9056322579087257
MENTAL RETARDATION, X-LINKED 98; MRX98	0.004195194	1.9056322579087257
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.004195194	1.9056322579087257
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.004195194	1.9056322579087257
WOLMAN DISEASE	0.004195194	1.9056322579087257
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.004195194	1.9056322579087257
X SMALL RINGS	0.004195194	1.9056322579087257
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.004195194	1.9056322579087257
2P21 MICRODELETION SYNDROME	0.004195194	1.9056322579087257
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.003925088	1.7829388361850356
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.003925088	1.7829388361850356
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.003925088	1.7829388361850356
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.003925088	1.7829388361850356
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.003925088	1.7829388361850356
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.003925088	1.7829388361850356
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.003925088	1.7829388361850356
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.003925088	1.7829388361850356
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.003925088	1.7829388361850356
JOUBERT SYNDROME 3; JBTS3	0.003925088	1.7829388361850356
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.003925088	1.7829388361850356
LATERAL MENINGOCELE SYNDROME	0.003925088	1.7829388361850356
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.003925088	1.7829388361850356
SPINOCEREBELLAR ATAXIA 47; SCA47	0.003925088	1.7829388361850356
VERVERI-BRADY SYNDROME; VERBRAS	0.003925088	1.7829388361850356
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.00364964	1.6578188550407924
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.00364964	1.6578188550407924
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.00364964	1.6578188550407924
NEPHRONOPHTHISIS 4	0.00364964	1.6578188550407924
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00364964	1.6578188550407924
CRYPTOSPORIDIOSIS	0.00364964	1.6578188550407924
SERKAL SYNDROME	0.00364964	1.6578188550407924
ROTHMUND-THOMSON SYNDROME TYPE 2	0.00364964	1.6578188550407924
FAMILIAL HYPOALDOSTERONISM	0.00364964	1.6578188550407924
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.00364964	1.6578188550407924
CINCA SYNDROME; CINCA	0.00364964	1.6578188550407924
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00364964	1.6578188550407924
ESOPHAGEAL ATRESIA	0.00364964	1.6578188550407924
INTESTINAL LYMPHANGIECTASIA	0.00364964	1.6578188550407924
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00364964	1.6578188550407924
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00364964	1.6578188550407924
FAMILIAL DYSAUTONOMIA	0.00364964	1.6578188550407924
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00364964	1.6578188550407924
DIAMOND-BLACKFAN ANEMIA 9	0.00364964	1.6578188550407924
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.00364964	1.6578188550407924
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00364964	1.6578188550407924
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.00364964	1.6578188550407924
CERNUNNOS-XLF DEFICIENCY	0.00364964	1.6578188550407924
2Q24 MICRODELETION SYNDROME	0.00364964	1.6578188550407924
EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE; EBSDM	0.00364964	1.6578188550407924
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00364964	1.6578188550407924
MAJEED SYNDROME	0.00364964	1.6578188550407924
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00364964	1.6578188550407924
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00364964	1.6578188550407924
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.00364964	1.6578188550407924
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.00364964	1.6578188550407924
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.00364964	1.6578188550407924
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.00364964	1.6578188550407924
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00364964	1.6578188550407924
COLOBOMA, OCULAR	0.00364964	1.6578188550407924
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.00364964	1.6578188550407924
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00364964	1.6578188550407924
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00364964	1.6578188550407924
ZIMMERMANN-LABAND SYNDROME	0.00364964	1.6578188550407924
ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IGE; EPKHE	0.00364964	1.6578188550407924
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.00364964	1.6578188550407924
HEREDITARY FRUCTOSE INTOLERANCE	0.00364964	1.6578188550407924
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00364964	1.6578188550407924
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00364964	1.6578188550407924
GENERALIZED JUVENILE POLYPOSIS/JUVENILE POLYPOSIS COLI	0.00364964	1.6578188550407924
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.00364964	1.6578188550407924
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.00364964	1.6578188550407924
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00364964	1.6578188550407924
CHYLOMICRON RETENTION DISEASE	0.00364964	1.6578188550407924
ACHALASIA-MICROCEPHALY SYNDROME	0.00364964	1.6578188550407924
CHYLOMICRON RETENTION DISEASE	0.00364964	1.6578188550407924
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00364964	1.6578188550407924
GAPO SYNDROME; GAPOS	0.00364964	1.6578188550407924
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.00364964	1.6578188550407924
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.00364964	1.6578188550407924
FORMIMINOTRANSFERASE DEFICIENCY	0.00364964	1.6578188550407924
LYSINE MALABSORPTION SYNDROME	0.00364964	1.6578188550407924
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00364964	1.6578188550407924
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00364964	1.6578188550407924
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00364964	1.6578188550407924
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00364964	1.6578188550407924
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.00364964	1.6578188550407924
HEREDITARY SPHEROCYTOSIS	0.00364964	1.6578188550407924
BARTH SYNDROME; BTHS	0.00364964	1.6578188550407924
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.00364964	1.6578188550407924
ALPHA-HEAVY CHAIN DISEASE	0.00364964	1.6578188550407924
ROWLEY-ROSENBERG SYNDROME	0.00364964	1.6578188550407924
LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS	0.00364964	1.6578188550407924
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00364964	1.6578188550407924
AROMATASE DEFICIENCY	0.00364964	1.6578188550407924
TYROSINE TRANSAMINASE DEFICIENCY	0.00364964	1.6578188550407924
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00364964	1.6578188550407924
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.00364964	1.6578188550407924
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00364964	1.6578188550407924
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.00364964	1.6578188550407924
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00364964	1.6578188550407924
THREONINEMIA	0.00364964	1.6578188550407924
EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE K14	0.00364964	1.6578188550407924
INTERLEUKIN 1, DEFECTIVE T-CELL RESPONSE TO	0.00364964	1.6578188550407924
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	0.00364964	1.6578188550407924
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00364964	1.6578188550407924
OSTEOPETROSIS AND RELATED DISORDERS	0.00364964	1.6578188550407924
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.00364964	1.6578188550407924
JUNCTIONAL EPIDERMOLYSIS BULLOSA, NON-HERLITZ TYPE	0.00364964	1.6578188550407924
AXENFELD-RIEGER SYNDROME	0.00364964	1.6578188550407924
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.00364964	1.6578188550407924
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00364964	1.6578188550407924
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.00364964	1.6578188550407924
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00364964	1.6578188550407924
GLYCOGEN STORAGE DISEASE IXA	0.00364964	1.6578188550407924
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00364964	1.6578188550407924
CITRULLINE TRANSPORT DEFECT	0.00364964	1.6578188550407924
SECONDARY SHORT BOWEL SYNDROME	0.00364964	1.6578188550407924
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00364964	1.6578188550407924
NEPHRONOPHTHISIS 1	0.00364964	1.6578188550407924
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00364964	1.6578188550407924
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.00364964	1.6578188550407924
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.00364964	1.6578188550407924
DIARRHEA 2, WITH MICROVILLOUS ATROPHY	0.00364964	1.6578188550407924
CUSHING SYNDROME	0.00364964	1.6578188550407924
NATHALIE SYNDROME	0.00364964	1.6578188550407924
MEHMO SYNDROME	0.00364964	1.6578188550407924
MILLER-DIEKER SYNDROME	0.00364964	1.6578188550407924
LINEAR NEVUS SEBACEUS SYNDROME	0.00364964	1.6578188550407924
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00364964	1.6578188550407924
20Q13.33 MICRODELETION SYNDROME	0.00364964	1.6578188550407924
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.00364964	1.6578188550407924
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.00364964	1.6578188550407924
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.00364964	1.6578188550407924
T-SUBSTANCE ANOMALY	0.00364964	1.6578188550407924
COFFIN-SIRIS SYNDROME 1; CSS1	0.003509104	1.5939815366718537
PETERS-PLUS SYNDROME; PTRPLS	0.003509104	1.5939815366718537
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.003509104	1.5939815366718537
OKAMOTO SYNDROME	0.003509104	1.5939815366718537
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.003509104	1.5939815366718537
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.003509104	1.5939815366718537
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.003509104	1.5939815366718537
AICARDI-GOUTIÈRES SYNDROME	0.003509104	1.5939815366718537
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.003509104	1.5939815366718537
CUTIS LAXA	0.003509104	1.5939815366718537
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.003509104	1.5939815366718537
LATERAL MENINGOCELE SYNDROME	0.003509104	1.5939815366718537
CREE MENTAL RETARDATION SYNDROME	0.003509104	1.5939815366718537
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.003509104	1.5939815366718537
CHAR SYNDROME	0.003509104	1.5939815366718537
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.003509104	1.5939815366718537
FETAL TRIMETHADIONE SYNDROME	0.003509104	1.5939815366718537
11Q22.2Q22.3 MICRODELETION SYNDROME	0.003509104	1.5939815366718537
TRISOMY 17P	0.003509104	1.5939815366718537
JOUBERT SYNDROME	0.003509104	1.5939815366718537
PERLMAN SYNDROME	0.003509104	1.5939815366718537
NOONAN SYNDROME 5; NS5	0.003509104	1.5939815366718537
22Q11.2 DELETION SYNDROME	0.003509104	1.5939815366718537
RUBINSTEIN-TAYBI SYNDROME	0.003509104	1.5939815366718537
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.003509104	1.5939815366718537
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.003509104	1.5939815366718537
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0030720420000000005	1.3954497295835278
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.0030720420000000005	1.3954497295835278
CODAS SYNDROME	0.0030720420000000005	1.3954497295835278
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.0030720420000000005	1.3954497295835278
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.0030720420000000005	1.3954497295835278
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.0030720420000000005	1.3954497295835278
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.0030720420000000005	1.3954497295835278
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.0030720420000000005	1.3954497295835278
HELSMOORTEL-VAN DER AA SYNDROME	0.0030720420000000005	1.3954497295835278
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.0030720420000000005	1.3954497295835278
ARIMA SYNDROME	0.0030720420000000005	1.3954497295835278
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.0030720420000000005	1.3954497295835278
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.0030720420000000005	1.3954497295835278
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.0030720420000000005	1.3954497295835278
HYPOTONIA-CYSTINURIA SYNDROME	0.0030720420000000005	1.3954497295835278
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.0030720420000000005	1.3954497295835278
LEIGH SYNDROME; LS	0.0030720420000000005	1.3954497295835278
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.0030720420000000005	1.3954497295835278
AURICULOCONDYLAR SYNDROME	0.0030720420000000005	1.3954497295835278
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0030720420000000005	1.3954497295835278
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.0030720420000000005	1.3954497295835278
AU-KLINE SYNDROME; AUKS	0.0030720420000000005	1.3954497295835278
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.0030720420000000005	1.3954497295835278
KABUKI SYNDROME 1	0.0030720420000000005	1.3954497295835278
PHELAN-MCDERMID SYNDROME	0.0030720420000000005	1.3954497295835278
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.0030720420000000005	1.3954497295835278
JOUBERT SYNDROME 21	0.0030720420000000005	1.3954497295835278
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0030720420000000005	1.3954497295835278
CRANIOSYNOSTOSIS 6; CRS6	0.0030720420000000005	1.3954497295835278
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.0030720420000000005	1.3954497295835278
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.0030720420000000005	1.3954497295835278
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.0030720420000000005	1.3954497295835278
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.0030720420000000005	1.3954497295835278
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.0030720420000000005	1.3954497295835278
JOUBERT SYNDROME 7	0.0030720420000000005	1.3954497295835278
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.0030720420000000005	1.3954497295835278
PONTINE TEGMENTAL CAP DYSPLASIA	0.0030720420000000005	1.3954497295835278
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.0030720420000000005	1.3954497295835278
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0030720420000000005	1.3954497295835278
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.003072042	1.3954497295835275
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.003072042	1.3954497295835275
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.003072042	1.3954497295835275
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.003072042	1.3954497295835275
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.003072042	1.3954497295835275
JOUBERT SYNDROME 30; JBTS30	0.003072042	1.3954497295835275
JOUBERT SYNDROME 26	0.003072042	1.3954497295835275
TEEBI-SHALTOUT SYNDROME; TBSH	0.0029635499999999997	1.3461681338039202
TURNER SYNDROME	0.0029635499999999997	1.3461681338039202
MEIER-GORLIN SYNDROME 8; MGORS8	0.0029635499999999997	1.3461681338039202
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.0029635499999999997	1.3461681338039202
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.0029635499999999997	1.3461681338039202
FRONTONASAL DYSPLASIA 1; FND1	0.0029635499999999997	1.3461681338039202
MENTAL RETARDATION, BUENOS AIRES TYPE	0.0029635499999999997	1.3461681338039202
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.0029635499999999997	1.3461681338039202
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.0029635499999999997	1.3461681338039202
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.0029635499999999997	1.3461681338039202
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.0029635499999999997	1.3461681338039202
MONOSOMY X	0.0029635499999999997	1.3461681338039202
BRANCHIOOCULOFACIAL SYNDROME	0.0029635499999999997	1.3461681338039202
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.0029635499999999997	1.3461681338039202
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.0029635499999999997	1.3461681338039202
MOSAIC MONOSOMY X	0.0029635499999999997	1.3461681338039202
CORNELIA DE LANGE SYNDROME 1	0.0029635499999999997	1.3461681338039202
NEUROFACIODIGITORENAL SYNDROME	0.0029635499999999997	1.3461681338039202
SAETHRE-CHOTZEN SYNDROME	0.0029635499999999997	1.3461681338039202
HYPERTELORISM, TEEBI TYPE	0.0029635499999999997	1.3461681338039202
CONGENITAL MYASTHENIC SYNDROME	0.0029635499999999997	1.3461681338039202
TERMINAL OSSEOUS DYSPLASIA; TOD	0.0029635499999999997	1.3461681338039202
4Q21 MICRODELETION SYNDROME	0.0029635499999999997	1.3461681338039202
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.0029635499999999997	1.3461681338039202
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.0029635499999999997	1.3461681338039202
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.0029635499999999997	1.3461681338039202
GABRIELE-DE VRIES SYNDROME	0.0029635499999999997	1.3461681338039202
POLYVALVULAR HEART DISEASE SYNDROME	0.0029635499999999997	1.3461681338039202
MONOSOMY 13Q14	0.0029635499999999997	1.3461681338039202
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.0029635499999999997	1.3461681338039202
SCARF SYNDROME	0.0029635499999999997	1.3461681338039202
WIDOW'S PEAK SYNDROME	0.0029635499999999997	1.3461681338039202
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.0029635499999999997	1.3461681338039202
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.0029635499999999997	1.3461681338039202
PROTEUS SYNDROME	0.0029635499999999997	1.3461681338039202
AYME-GRIPP SYNDROME; AYGRP	0.0029635499999999997	1.3461681338039202
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.0029635499999999997	1.3461681338039202
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.0029635499999999997	1.3461681338039202
NOONAN SYNDROME 8; NS8	0.0029635499999999997	1.3461681338039202
SHPRINTZEN-GOLDBERG SYNDROME	0.0029635499999999997	1.3461681338039202
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.0029635499999999997	1.3461681338039202
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0029056919999999997	1.3198866147184898
JABERI-ELAHI SYNDROME; JABELS	0.0029056919999999997	1.3198866147184898
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.0029056919999999997	1.3198866147184898
OROFACIODIGITAL SYNDROME VI	0.0029056919999999997	1.3198866147184898
AL-RAQAD SYNDROME; ARS	0.0029056919999999997	1.3198866147184898
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.0029056919999999997	1.3198866147184898
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.0029056919999999997	1.3198866147184898
MEND SYNDROME	0.0029056919999999997	1.3198866147184898
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.0029056919999999997	1.3198866147184898
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.0029056919999999997	1.3198866147184898
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0029056919999999997	1.3198866147184898
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.0029056919999999997	1.3198866147184898
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.0029056919999999997	1.3198866147184898
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0029056919999999997	1.3198866147184898
NOONAN SYNDROME 6; NS6	0.0029056919999999997	1.3198866147184898
WHITE-SUTTON SYNDROME; WHSUS	0.0029056919999999997	1.3198866147184898
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0029056919999999997	1.3198866147184898
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.0029056919999999997	1.3198866147184898
OROFACIODIGITAL SYNDROME XIV; OFD14	0.0029056919999999997	1.3198866147184898
C SYNDROME	0.0029056919999999997	1.3198866147184898
SIALURIA	0.0029056919999999997	1.3198866147184898
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.0029056919999999997	1.3198866147184898
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.0029056919999999997	1.3198866147184898
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0029056919999999997	1.3198866147184898
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.0029056919999999997	1.3198866147184898
XIA-GIBBS SYNDROME	0.0029056919999999997	1.3198866147184898
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.0029056919999999997	1.3198866147184898
RITSCHER-SCHINZEL SYNDROME 1	0.0029056919999999997	1.3198866147184898
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0029056919999999997	1.3198866147184898
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.0029056919999999997	1.3198866147184898
DISTAL MONOSOMY 12Q	0.0029056919999999997	1.3198866147184898
AL KAISSI SYNDROME; ALKAS	0.0029056919999999997	1.3198866147184898
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.0029056919999999997	1.3198866147184898
TEMTAMY SYNDROME; TEMTYS	0.0029056919999999997	1.3198866147184898
COFFIN-SIRIS SYNDROME 7; CSS7	0.0029056919999999997	1.3198866147184898
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.0029056919999999997	1.3198866147184898
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0029056919999999997	1.3198866147184898
MEVALONIC ACIDURIA; MEVA	0.0029056919999999997	1.3198866147184898
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.0029056919999999997	1.3198866147184898
CHROMOSOME 10Q26 DELETION SYNDROME	0.0029056919999999997	1.3198866147184898
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0029056919999999997	1.3198866147184898
LAMB-SHAFFER SYNDROME	0.0029056919999999997	1.3198866147184898
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.0029056919999999997	1.3198866147184898
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.0029056919999999997	1.3198866147184898
CHROMOSOME 16P13.2 DELETION SYNDROME	0.0029056919999999997	1.3198866147184898
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.0029056919999999997	1.3198866147184898
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0029056919999999997	1.3198866147184898
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.0029056919999999997	1.3198866147184898
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.0029056919999999997	1.3198866147184898
ADAMS-OLIVER SYNDROME 2; AOS2	0.0029056919999999997	1.3198866147184898
OGDEN SYNDROME	0.0029056919999999997	1.3198866147184898
EMANUEL SYNDROME	0.0029056919999999997	1.3198866147184898
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.0029056919999999997	1.3198866147184898
JOUBERT SYNDROME 2	0.0029056919999999997	1.3198866147184898
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.0029056919999999997	1.3198866147184898
ZTTK SYNDROME; ZTTKS	0.0029056919999999997	1.3198866147184898
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.0029056919999999997	1.3198866147184898
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0029056919999999997	1.3198866147184898
LARSEN-LIKE SYNDROME	0.0029056919999999997	1.3198866147184898
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0029056919999999997	1.3198866147184898
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.0029056919999999997	1.3198866147184898
BOHRING-OPITZ SYNDROME	0.0029056919999999997	1.3198866147184898
MEND SYNDROME; MEND	0.0029056919999999997	1.3198866147184898
PEROXISOME BIOGENESIS DISORDER 10B	0.0029056919999999997	1.3198866147184898
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0029056919999999997	1.3198866147184898
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0029056919999999997	1.3198866147184898
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0029056919999999997	1.3198866147184898
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.0029056919999999997	1.3198866147184898
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.0029056919999999997	1.3198866147184898
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0029056919999999997	1.3198866147184898
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.0029056919999999997	1.3198866147184898
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0029056919999999997	1.3198866147184898
DIAPHANOSPONDYLODYSOSTOSIS	0.0029056919999999997	1.3198866147184898
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.0029056919999999997	1.3198866147184898
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.0029056919999999997	1.3198866147184898
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.0029056919999999997	1.3198866147184898
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.0029056919999999997	1.3198866147184898
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.0029056919999999997	1.3198866147184898
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0025264880000000003	1.1476363267155942
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.0025264880000000003	1.1476363267155942
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.0025264880000000003	1.1476363267155942
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0025264880000000003	1.1476363267155942
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0025264880000000003	1.1476363267155942
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.0025264880000000003	1.1476363267155942
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.0025264880000000003	1.1476363267155942
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.0025264880000000003	1.1476363267155942
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.0025264880000000003	1.1476363267155942
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0025264880000000003	1.1476363267155942
MYASTHENIC SYNDROME, CONGENITAL, 13	0.0025264880000000003	1.1476363267155942
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0025264880000000003	1.1476363267155942
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.0025264880000000003	1.1476363267155942
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.0025264880000000003	1.1476363267155942
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0025264880000000003	1.1476363267155942
COFFIN-SIRIS SYNDROME 8; CSS8	0.0025264880000000003	1.1476363267155942
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.0025264880000000003	1.1476363267155942
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0025264880000000003	1.1476363267155942
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.0025264880000000003	1.1476363267155942
PALLISTER-KILLIAN SYNDROME	0.0025264880000000003	1.1476363267155942
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0025264880000000003	1.1476363267155942
PRIMROSE SYNDROME; PRIMS	0.0025264880000000003	1.1476363267155942
LEGIUS SYNDROME	0.0025264880000000003	1.1476363267155942
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.0025264880000000003	1.1476363267155942
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0025264880000000003	1.1476363267155942
WARBURG MICRO SYNDROME 1	0.0025264880000000003	1.1476363267155942
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0025264880000000003	1.1476363267155942
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.0025264880000000003	1.1476363267155942
MOWAT-WILSON SYNDROME; MOWS	0.0025264880000000003	1.1476363267155942
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.002360138	1.0720732118505567
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.002360138	1.0720732118505567
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.002360138	1.0720732118505567
MARSHALL-SMITH SYNDROME; MRSHSS	0.002360138	1.0720732118505567
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.002360138	1.0720732118505567
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.002360138	1.0720732118505567
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.002360138	1.0720732118505567
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.002360138	1.0720732118505567
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.002360138	1.0720732118505567
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.002360138	1.0720732118505567
COFFIN-SIRIS SYNDROME 10; CSS10	0.002360138	1.0720732118505567
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.002360138	1.0720732118505567
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.002360138	1.0720732118505567
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.002360138	1.0720732118505567
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.002360138	1.0720732118505567
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.002360138	1.0720732118505567
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.002360138	1.0720732118505567
GLUTAMINE DEFICIENCY, CONGENITAL	0.002360138	1.0720732118505567
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.002360138	1.0720732118505567
NON-DISTAL MONOSOMY 20Q	0.002360138	1.0720732118505567
NOONAN SYNDROME 7; NS7	0.002360138	1.0720732118505567
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.002360138	1.0720732118505567
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.002360138	1.0720732118505567
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.002360138	1.0720732118505567
PSEUDOTRISOMY 13 SYNDROME	0.002360138	1.0720732118505567
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.002360138	1.0720732118505567
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.002360138	1.0720732118505567
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.002360138	1.0720732118505567
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.002360138	1.0720732118505567
LISSENCEPHALY, X-LINKED, 2	0.002360138	1.0720732118505567
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.002360138	1.0720732118505567
JUVENILE POLYPOSIS OF INFANCY	0.002360138	1.0720732118505567
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.002360138	1.0720732118505567
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.002360138	1.0720732118505567
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.002110504	0.9586790272024124
NOONAN SYNDROME 9; NS9	0.002110504	0.9586790272024124
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.002110504	0.9586790272024124
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.002110504	0.9586790272024124
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.002110504	0.9586790272024124
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.002110504	0.9586790272024124
MONOSOMY 22Q13.3	0.002110504	0.9586790272024124
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.002110504	0.9586790272024124
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.002110504	0.9586790272024124
PALLISTER-HALL SYNDROME	0.002110504	0.9586790272024124
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.002110504	0.9586790272024124
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.002110504	0.9586790272024124
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.002110504	0.9586790272024124
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.002110504	0.9586790272024124
SMITH-LEMLI-OPITZ SYNDROME	0.002110504	0.9586790272024124
AARSKOG-SCOTT SYNDROME	0.002110504	0.9586790272024124
CHARGE SYNDROME	0.002110504	0.9586790272024124
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.002110504	0.9586790272024124
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.002110504	0.9586790272024124
HYPERTRICHOSIS CUBITI	0.002110504	0.9586790272024124
20Q11.2 MICRODUPLICATION SYNDROME	0.002110504	0.9586790272024124
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.002110504	0.9586790272024124
CODAS SYNDROME	0.002110504	0.9586790272024124
COFFIN-SIRIS SYNDROME	0.002110504	0.9586790272024124
JOUBERT SYNDROME WITH RENAL DEFECT	0.002110504	0.9586790272024124
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.002110504	0.9586790272024124
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.002110504	0.9586790272024124
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.002110504	0.9586790272024124
COFFIN-SIRIS SYNDROME 5	0.002110504	0.9586790272024124
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.002110504	0.9586790272024124
NOONAN SYNDROME 2; NS2	0.002110504	0.9586790272024124
JOUBERT SYNDROME WITH OCULAR DEFECT	0.002110504	0.9586790272024124
CDAGS SYNDROME	0.002110504	0.9586790272024124
OCULOFACIOCARDIODENTAL SYNDROME	0.002110504	0.9586790272024124
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.002110504	0.9586790272024124
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.002110504	0.9586790272024124
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.002110504	0.9586790272024124
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.002110504	0.9586790272024124
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.002110504	0.9586790272024124
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.002110504	0.9586790272024124
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.002110504	0.9586790272024124
WOLF-HIRSCHHORN SYNDROME	0.002110504	0.9586790272024124
MUENKE SYNDROME	0.002110504	0.9586790272024124
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.002110504	0.9586790272024124
POPOV-CHANG SYNDROME; POPCHAS	0.002110504	0.9586790272024124
RUVALCABA SYNDROME	0.002110504	0.9586790272024124
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.002110504	0.9586790272024124
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.002110504	0.9586790272024124
ISOLATED COMPLEX I DEFICIENCY	0.002110504	0.9586790272024124
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.002110504	0.9586790272024124
14Q22Q23 MICRODELETION SYNDROME	0.002110504	0.9586790272024124
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.002110504	0.9586790272024124
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.002110504	0.9586790272024124
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.002110504	0.9586790272024124
CORNELIA DE LANGE SYNDROME 3	0.002110504	0.9586790272024124
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.002110504	0.9586790272024124
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.002110504	0.9586790272024124
CHAR SYNDROME	0.002110504	0.9586790272024124
LATHOSTEROLOSIS	0.002110504	0.9586790272024124
PRADER-WILLI-LIKE SYNDROME	0.002110504	0.9586790272024124
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.002110504	0.9586790272024124
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.002110504	0.9586790272024124
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.002110504	0.9586790272024124
MONOSOMY 18P	0.002110504	0.9586790272024124
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.002110504	0.9586790272024124
FETAL HYDANTOIN SYNDROME	0.002110504	0.9586790272024124
FETAL ALCOHOL SYNDROME	0.002110504	0.9586790272024124
PHACE SYNDROME	0.002110504	0.9586790272024124
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.002110504	0.9586790272024124
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.002110504	0.9586790272024124
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.002110504	0.9586790272024124
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.002110504	0.9586790272024124
FRIAS SYNDROME	0.002110504	0.9586790272024124
BOHRING-OPITZ SYNDROME	0.0019441539999999998	0.8831159123373746
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.0019441539999999998	0.8831159123373746
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.0019441539999999998	0.8831159123373746
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.0019441539999999998	0.8831159123373746
HARTSFIELD SYNDROME; HRTFDS	0.0019441539999999998	0.8831159123373746
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.0019441539999999998	0.8831159123373746
EAR-PATELLA-SHORT STATURE SYNDROME	0.0019441539999999998	0.8831159123373746
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.0019441539999999998	0.8831159123373746
15Q14 MICRODELETION SYNDROME	0.0019441539999999998	0.8831159123373746
16P13.11 MICRODELETION SYNDROME	0.0019441539999999998	0.8831159123373746
19P13.3 MICRODUPLICATION SYNDROME	0.0019441539999999998	0.8831159123373746
TEMTAMY SYNDROME	0.0019441539999999998	0.8831159123373746
BRESEK SYNDROME	0.0019441539999999998	0.8831159123373746
GENITOPATELLAR SYNDROME	0.0019441539999999998	0.8831159123373746
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.0019441539999999998	0.8831159123373746
SWEENEY-COX SYNDROME; SWCOS	0.0019441539999999998	0.8831159123373746
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.0019441539999999998	0.8831159123373746
RAINE SYNDROME	0.0019441539999999998	0.8831159123373746
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.0019441539999999998	0.8831159123373746
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.0019441539999999998	0.8831159123373746
19P13.12 MICRODELETION SYNDROME	0.0019441539999999998	0.8831159123373746
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0019441539999999998	0.8831159123373746
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.0019441539999999998	0.8831159123373746
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.0019441539999999998	0.8831159123373746
TURNPENNY-FRY SYNDROME; TPFS	0.0019441539999999998	0.8831159123373746
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.0019441539999999998	0.8831159123373746
OTOPALATODIGITAL SYNDROME TYPE 2	0.0019441539999999998	0.8831159123373746
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.0019441539999999998	0.8831159123373746
WALKER-WARBURG SYNDROME	0.0019441539999999998	0.8831159123373746
2Q32Q33 MICRODELETION SYNDROME	0.0019441539999999998	0.8831159123373746
ALAZAMI SYNDROME; ALAZS	0.0019441539999999998	0.8831159123373746
3Q29 MICRODUPLICATION SYNDROME	0.0019441539999999998	0.8831159123373746
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0019441539999999998	0.8831159123373746
8P23.1 MICRODELETION SYNDROME	0.0019441539999999998	0.8831159123373746
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.0019441539999999998	0.8831159123373746
6Q16 MICRODELETION SYNDROME	0.0019441539999999998	0.8831159123373746
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.0019441539999999998	0.8831159123373746
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.0019441539999999998	0.8831159123373746
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.0019441539999999998	0.8831159123373746
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.0019441539999999998	0.8831159123373746
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.0019441539999999998	0.8831159123373746
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.0019441539999999998	0.8831159123373746
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.0019441539999999998	0.8831159123373746
3C SYNDROME	0.0019441539999999998	0.8831159123373746
MONOSOMY 9Q22.3	0.0019441539999999998	0.8831159123373746
DIAMOND-BLACKFAN ANEMIA 5	0.0019441539999999998	0.8831159123373746
CATEL-MANZKE SYNDROME; CATMANS	0.0019441539999999998	0.8831159123373746
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.0019441539999999998	0.8831159123373746
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.0019441539999999998	0.8831159123373746
OGDEN SYNDROME; OGDNS	0.0019441539999999998	0.8831159123373746
CEREBELLOFACIODENTAL SYNDROME	0.0019441539999999998	0.8831159123373746
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.0019441539999999998	0.8831159123373746
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.0019441539999999998	0.8831159123373746
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.0019441539999999998	0.8831159123373746
DE BARSY SYNDROME	0.0019441539999999998	0.8831159123373746
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.0019441539999999998	0.8831159123373746
GLASS SYNDROME	0.0019441539999999998	0.8831159123373746
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.0019441539999999998	0.8831159123373746
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.0019441539999999998	0.8831159123373746
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.0019441539999999998	0.8831159123373746
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.0019441539999999998	0.8831159123373746
3Q29 MICRODELETION SYNDROME	0.0019441539999999998	0.8831159123373746
CHROMOSOME 15Q14 DELETION SYNDROME	0.0019441539999999998	0.8831159123373746
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.0019441539999999998	0.8831159123373746
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0019441539999999998	0.8831159123373746
611961 STEVENSON-CAREY SYNDROME	0.0019441539999999998	0.8831159123373746
DOORS SYNDROME	0.0019441539999999998	0.8831159123373746
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.0019441539999999998	0.8831159123373746
BILATERAL POLYMICROGYRIA	0.0019441539999999998	0.8831159123373746
OPITZ G/BBB SYNDROME	0.0019441539999999998	0.8831159123373746
OROFACIODIGITAL SYNDROME TYPE 4	0.0019441539999999998	0.8831159123373746
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0019441539999999998	0.8831159123373746
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.0019441539999999998	0.8831159123373746
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.0019441539999999998	0.8831159123373746
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.0019441539999999998	0.8831159123373746
10Q22.3Q23.3 MICRODELETION SYNDROME	0.0019441539999999998	0.8831159123373746
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.0019441539999999998	0.8831159123373746
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0019441539999999998	0.8831159123373746
PHENOBARBITAL EMBRYOPATHY	0.0019441539999999998	0.8831159123373746
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0019441539999999998	0.8831159123373746
WRINKLY SKIN SYNDROME	0.0019441539999999998	0.8831159123373746
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.0019441539999999998	0.8831159123373746
MOSAIC TRISOMY 9	0.0019441539999999998	0.8831159123373746
PFEIFFER SYNDROME TYPE 2	0.0019441539999999998	0.8831159123373746
17P13.3 MICRODUPLICATION SYNDROME	0.0019441539999999998	0.8831159123373746
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.0019441539999999998	0.8831159123373746
ELSAHY-WATERS SYNDROME; ESWS	0.0019441539999999998	0.8831159123373746
AYMÉ-GRIPP SYNDROME	0.0019441539999999998	0.8831159123373746
NOONAN SYNDROME 3; NS3	0.0019441539999999998	0.8831159123373746
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.0019441539999999998	0.8831159123373746
TRISOMY 12P	0.0019441539999999998	0.8831159123373746
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.0019441539999999998	0.8831159123373746
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.0019441539999999998	0.8831159123373746
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.0019441539999999998	0.8831159123373746
RECOMBINANT 8 SYNDROME	0.0019441539999999998	0.8831159123373746
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0019441539999999998	0.8831159123373746
ICF SYNDROME	0.0019441539999999998	0.8831159123373746
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.0019441539999999998	0.8831159123373746
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.0019441539999999998	0.8831159123373746
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.0019441539999999998	0.8831159123373746
DISTAL MONOSOMY 6P	0.0019441539999999998	0.8831159123373746
FORSYTHE-WAKELING SYNDROME; FWS	0.0019441539999999998	0.8831159123373746
DISTAL MONOSOMY 1Q	0.0019441539999999998	0.8831159123373746
HOLMES-GANG SYNDROME	0.0019441539999999998	0.8831159123373746
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.0019441539999999998	0.8831159123373746
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.0019441539999999998	0.8831159123373746
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.0019441539999999998	0.8831159123373746
19P13.13 MICRODELETION SYNDROME	0.0019441539999999998	0.8831159123373746
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00156495	0.710865624334479
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.00156495	0.710865624334479
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.00156495	0.710865624334479
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00156495	0.710865624334479
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00156495	0.710865624334479
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00156495	0.710865624334479
PACHYDERMOPERIOSTOSIS	0.00156495	0.710865624334479
WERNICKE-KORSAKOFF SYNDROME	0.00156495	0.710865624334479
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00156495	0.710865624334479
BRANCHIO-OCULO-FACIAL SYNDROME	0.00156495	0.710865624334479
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00156495	0.710865624334479
JACKSON-WEISS SYNDROME	0.00156495	0.710865624334479
OCULOCEREBROCUTANEOUS SYNDROME	0.00156495	0.710865624334479
KAWASAKI DISEASE	0.00156495	0.710865624334479
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00156495	0.710865624334479
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00156495	0.710865624334479
KEIPERT SYNDROME	0.00156495	0.710865624334479
HARTSFIELD SYNDROME	0.00156495	0.710865624334479
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00156495	0.710865624334479
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00156495	0.710865624334479
OCULOPHARYNGEAL MUSCULAR DYSTROPHY	0.00156495	0.710865624334479
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00156495	0.710865624334479
PROTEUS SYNDROME	0.00156495	0.710865624334479
REFSUM DISEASE	0.00156495	0.710865624334479
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.00156495	0.710865624334479
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.00156495	0.710865624334479
DERMOODONTODYSPLASIA	0.00156495	0.710865624334479
PROGRESSIVE HEMIFACIAL ATROPHY	0.00156495	0.710865624334479
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.00156495	0.710865624334479
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.00156495	0.710865624334479
MACHADO-JOSEPH DISEASE; MJD	0.00156495	0.710865624334479
BLEPHAROPTOSIS-MYOPIA-ECTOPIA LENTIS SYNDROME	0.00156495	0.710865624334479
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.00156495	0.710865624334479
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.00156495	0.710865624334479
POSTERIOR FUSION OF LUMBOSACRAL VERTEBRAE-BLEPHAROPTOSIS SYNDROME	0.00156495	0.710865624334479
SPINOCEREBELLAR ATAXIA TYPE 36	0.00156495	0.710865624334479
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.00156495	0.710865624334479
%300245 PTOSIS, HEREDITARY CONGENITAL 2;;PTOS2;;PTOSIS, X-LINKED; PTOSX	0.00156495	0.710865624334479
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00156495	0.710865624334479
RHYNS SYNDROME	0.00156495	0.710865624334479
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00156495	0.710865624334479
NOONAN SYNDROME	0.00156495	0.710865624334479
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00156495	0.710865624334479
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00156495	0.710865624334479
NOONAN SYNDROME 10; NS10	0.00156495	0.710865624334479
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.00156495	0.710865624334479
PROLACTINOMA	0.00156495	0.710865624334479
2P15-16.1 MICRODELETION SYNDROME	0.00156495	0.710865624334479
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00156495	0.710865624334479
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.00156495	0.710865624334479
DEAFNESS, X-LINKED 7; DFNX7	0.00156495	0.710865624334479
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.00156495	0.710865624334479
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.00156495	0.710865624334479
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00156495	0.710865624334479
ACROCRANIOFACIAL DYSOSTOSIS	0.00156495	0.710865624334479
RING CHROMOSOME 1 SYNDROME	0.00156495	0.710865624334479
X-LINKED CENTRONUCLEAR MYOPATHY	0.00156495	0.710865624334479
CENTRONUCLEAR MYOPATHY	0.00156495	0.710865624334479
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00156495	0.710865624334479
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.00156495	0.710865624334479
THYMOMA	0.00156495	0.710865624334479
MALIGNANT ATROPHIC PAPULOSIS	0.00156495	0.710865624334479
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.00156495	0.710865624334479
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00156495	0.710865624334479
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00156495	0.710865624334479
OPHTHALMOPLEGIA, FAMILIAL STATIC	0.00156495	0.710865624334479
CAREY-FINEMAN-ZITER SYNDROME	0.00156495	0.710865624334479
REFSUM DISEASE	0.00156495	0.710865624334479
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00156495	0.710865624334479
DILATED CARDIOMYOPATHY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.00156495	0.710865624334479
PURPURA SIMPLEX	0.00156495	0.710865624334479
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.00156495	0.710865624334479
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.00156495	0.710865624334479
FREEMAN-SHELDON SYNDROME	0.00156495	0.710865624334479
PFEIFFER SYNDROME	0.00156495	0.710865624334479
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.00156495	0.710865624334479
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00156495	0.710865624334479
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.00156495	0.710865624334479
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00156495	0.710865624334479
BULBAR PALSY, PROGRESSIVE, OF CHILDHOOD	0.00156495	0.710865624334479
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00156495	0.710865624334479
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00156495	0.710865624334479
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00156495	0.710865624334479
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.00156495	0.710865624334479
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.00156495	0.710865624334479
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00156495	0.710865624334479
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00156495	0.710865624334479
WAARDENBURG SYNDROME TYPE 2	0.00156495	0.710865624334479
WAARDENBURG SYNDROME TYPE 1	0.00156495	0.710865624334479
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.00156495	0.710865624334479
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00156495	0.710865624334479
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00156495	0.710865624334479
TRISOMY 5P	0.00156495	0.710865624334479
AASE-SMITH SYNDROME I	0.00156495	0.710865624334479
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.00156495	0.710865624334479
WAGR SYNDROME	0.00156495	0.710865624334479
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00156495	0.710865624334479
PAROXYSMAL HEMICRANIA	0.00156495	0.710865624334479
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00156495	0.710865624334479
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00156495	0.710865624334479
INHALATIONAL BOTULISM	0.00156495	0.710865624334479
IATROGENIC BOTULISM	0.00156495	0.710865624334479
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.00156495	0.710865624334479
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00156495	0.710865624334479
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00156495	0.710865624334479
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.00156495	0.710865624334479
TYPICAL NEMALINE MYOPATHY	0.00156495	0.710865624334479
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00156495	0.710865624334479
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00156495	0.710865624334479
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00156495	0.710865624334479
NAGER SYNDROME	0.00156495	0.710865624334479
HOLOPROSENCEPHALY 4	0.00156495	0.710865624334479
ISOLATED CONGENITAL ALACRIMA	0.00156495	0.710865624334479
NON-FUNCTIONING PITUITARY ADENOMA	0.00156495	0.710865624334479
TSH-SECRETING PITUITARY ADENOMA	0.00156495	0.710865624334479
VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI; VIPB	0.00156495	0.710865624334479
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00156495	0.710865624334479
KABUKI SYNDROME	0.00156495	0.710865624334479
HYPERTELORISM, TEEBI TYPE; TBHS	0.00156495	0.710865624334479
MESOMELIA-SYNOSTOSES SYNDROME	0.00156495	0.710865624334479
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.00156495	0.710865624334479
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00156495	0.710865624334479
JUBERG-HAYWARD SYNDROME	0.00156495	0.710865624334479
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00156495	0.710865624334479
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT	0.00156495	0.710865624334479
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00156495	0.710865624334479
MCDONOUGH SYNDROME	0.00156495	0.710865624334479
GOOD SYNDROME	0.00156495	0.710865624334479
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00156495	0.710865624334479
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.00156495	0.710865624334479
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.00156495	0.710865624334479
PITUITARY APOPLEXY	0.00156495	0.710865624334479
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00156495	0.710865624334479
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00156495	0.710865624334479
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.00156495	0.710865624334479
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00156495	0.710865624334479
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00156495	0.710865624334479
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.00156495	0.710865624334479
OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA	0.00156495	0.710865624334479
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00156495	0.710865624334479
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00156495	0.710865624334479
MACROSTOMIA-PREAURICULAR TAGS-EXTERNAL OPHTHALMOPLEGIA SYNDROME	0.00156495	0.710865624334479
CROUZON DISEASE	0.00156495	0.710865624334479
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00156495	0.710865624334479
CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	0.00156495	0.710865624334479
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00156495	0.710865624334479
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00156495	0.710865624334479
OCULOGASTROINTESTINAL MUSCULAR DYSTROPHY	0.00156495	0.710865624334479
FOODBORNE BOTULISM	0.00156495	0.710865624334479
SPINOCEREBELLAR ATAXIA TYPE 28	0.00156495	0.710865624334479
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.00156495	0.710865624334479
THYMIC TUMOR	0.00156495	0.710865624334479
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00156495	0.710865624334479
NON-DISTAL MONOSOMY 10Q	0.00156495	0.710865624334479
ACROCRANIOFACIAL DYSOSTOSIS	0.00156495	0.710865624334479
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.00156495	0.710865624334479
WOUND BOTULISM	0.00156495	0.710865624334479
INFANT BOTULISM	0.00156495	0.710865624334479
INTESTINAL BOTULISM	0.00156495	0.710865624334479
ADULT INTESTINAL BOTULISM	0.00156495	0.710865624334479
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.00156495	0.710865624334479
MYASTHENIA GRAVIS; MG	0.00156495	0.710865624334479
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.00156495	0.710865624334479
CLUSTER HEADACHE, FAMILIAL	0.00156495	0.710865624334479
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00156495	0.710865624334479
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00156495	0.710865624334479
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00156495	0.710865624334479
CHARGE SYNDROME	0.00156495	0.710865624334479
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00156495	0.710865624334479
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.00156495	0.710865624334479
TETRASOMY 12P	0.00156495	0.710865624334479
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00156495	0.710865624334479
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9	0.00156495	0.710865624334479
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.00156495	0.710865624334479
MELAS	0.00156495	0.710865624334479
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00156495	0.710865624334479
MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8	0.00156495	0.710865624334479
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00156495	0.710865624334479
THYMIC EPITHELIAL NEOPLASM	0.00156495	0.710865624334479
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.00156495	0.710865624334479
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00156495	0.710865624334479
KALLMANN SYNDROME	0.00156495	0.710865624334479
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.00156495	0.710865624334479
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.00156495	0.710865624334479
MECKEL SYNDROME, TYPE 10; MKS10	0.00156495	0.710865624334479
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.00156495	0.710865624334479
TUKEL SYNDROME	0.00156495	0.710865624334479
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00156495	0.710865624334479
609612 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE;;CONGENITAL FIBROSIS SYNDROME WITH SYNERGISTIC DIVERGENCE;;EXTERNAL OPHTHALMOPLEGIA WITH SYNERGISTIC DIVERGENCEEXTERNAL OPHTHALMOPLEGIA, SYNERGISTIC DIVERGENCE, JAW WINKING, ANDOCULOCUTANEOUS HYPOPIGMENTATION, INCLUDED	0.00156495	0.710865624334479
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00156495	0.710865624334479
FRONTORHINY	0.00156495	0.710865624334479
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00156495	0.710865624334479
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 5; CFEOM5	0.00156495	0.710865624334479
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.00156495	0.710865624334479
GIANT CELL ARTERITIS	0.00156495	0.710865624334479
FOUNTAIN SYNDROME	0.00156495	0.710865624334479
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00156495	0.710865624334479
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.00156495	0.710865624334479
KEARNS-SAYRE SYNDROME; KSS	0.00156495	0.710865624334479
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00156495	0.710865624334479
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00156495	0.710865624334479
CHIME SYNDROME	0.00156495	0.710865624334479
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00156495	0.710865624334479
WAARDENBURG SYNDROME	0.00156495	0.710865624334479
MESOMELIA-SYNOSTOSES SYNDROME	0.00156495	0.710865624334479
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00156495	0.710865624334479
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.00156495	0.710865624334479
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00156495	0.710865624334479
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00156495	0.710865624334479
17Q24.2 MICRODELETION SYNDROME	0.00156495	0.710865624334479
SCLEROSTEOSIS	0.00156495	0.710865624334479
SIX2-RELATED FRONTONASAL DYSPLASIA	0.00156495	0.710865624334479
608028 THAI SYMPHALANGISM SYNDROME	0.00156495	0.710865624334479
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.00156495	0.710865624334479
SCARF SYNDROME	0.00156495	0.710865624334479
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00156495	0.710865624334479
9Q21.13 MICRODELETION SYNDROME	0.00156495	0.710865624334479
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00156495	0.710865624334479
ERDHEIM-CHESTER DISEASE	0.00156495	0.710865624334479
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00156495	0.710865624334479
MUCOPOLYSACCHARIDOSIS, TYPE II	0.00156495	0.710865624334479
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00156495	0.710865624334479
LOEYS-DIETZ SYNDROME 5	0.00156495	0.710865624334479
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00156495	0.710865624334479
MYASTHENIA GRAVIS	0.00156495	0.710865624334479
ALEXANDER DISEASE	0.00156495	0.710865624334479
FACIOCARDIOMELIC SYNDROME	0.00156495	0.710865624334479
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00156495	0.710865624334479
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.00156495	0.710865624334479
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.00156495	0.710865624334479
MOEBIUS SYNDROME	0.00156495	0.710865624334479
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00156495	0.710865624334479
NOONAN SYNDROME 4; NS4	0.00156495	0.710865624334479
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00156495	0.710865624334479
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00156495	0.710865624334479
RHYNS SYNDROME; RHYNS	0.00156495	0.710865624334479
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.00156495	0.710865624334479
NEONATAL ADRENOLEUKODYSTROPHY	0.00156495	0.710865624334479
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00156495	0.710865624334479
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00156495	0.710865624334479
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.00156495	0.710865624334479
ALLAN-HERNDON-DUDLEY SYNDROME	0.00156495	0.710865624334479
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.00156495	0.710865624334479
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.00156495	0.710865624334479
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.00156495	0.710865624334479
SALIH MYOPATHY; SALMY	0.00156495	0.710865624334479
CENANI-LENZ SYNDROME	0.00156495	0.710865624334479
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.001507092	0.6845841052490486
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.001507092	0.6845841052490486
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001507092	0.6845841052490486
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001507092	0.6845841052490486
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001507092	0.6845841052490486
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001507092	0.6845841052490486
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.001507092	0.6845841052490486
GENITOPATELLAR SYNDROME; GTPTS	0.001507092	0.6845841052490486
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.001507092	0.6845841052490486
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001507092	0.6845841052490486
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.001507092	0.6845841052490486
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001507092	0.6845841052490486
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001507092	0.6845841052490486
HYPERPROLINEMIA, TYPE I	0.001507092	0.6845841052490486
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.001507092	0.6845841052490486
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.001507092	0.6845841052490486
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001507092	0.6845841052490486
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001507092	0.6845841052490486
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001507092	0.6845841052490486
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.001507092	0.6845841052490486
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.001507092	0.6845841052490486
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001507092	0.6845841052490486
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.001507092	0.6845841052490486
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.001507092	0.6845841052490486
COFFIN-SIRIS SYNDROME 6; CSS6	0.001507092	0.6845841052490486
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001507092	0.6845841052490486
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001507092	0.6845841052490486
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.001507092	0.6845841052490486
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001507092	0.6845841052490486
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001507092	0.6845841052490486
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.001507092	0.6845841052490486
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001507092	0.6845841052490486
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.001507092	0.6845841052490486
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.001507092	0.6845841052490486
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001507092	0.6845841052490486
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001507092	0.6845841052490486
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.001507092	0.6845841052490486
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.001507092	0.6845841052490486
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001507092	0.6845841052490486
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001507092	0.6845841052490486
HOLOPROSENCEPHALY 1; HPE1	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.001507092	0.6845841052490486
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.001507092	0.6845841052490486
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001507092	0.6845841052490486
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.001507092	0.6845841052490486
MARINESCO-SJOGREN SYNDROME; MSS	0.001507092	0.6845841052490486
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001507092	0.6845841052490486
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.001507092	0.6845841052490486
TRICHOTHIODYSTROPHY	0.001507092	0.6845841052490486
TETRASOMY 9P	0.001507092	0.6845841052490486
METHYLMALONIC ACIDURIA, CBLB TYPE	0.001507092	0.6845841052490486
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.001507092	0.6845841052490486
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.001507092	0.6845841052490486
SIALIDOSIS TYPE 2	0.001507092	0.6845841052490486
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.001507092	0.6845841052490486
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.001507092	0.6845841052490486
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001507092	0.6845841052490486
INFANTILE LIVER FAILURE SYNDROME 1	0.001507092	0.6845841052490486
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001507092	0.6845841052490486
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.001507092	0.6845841052490486
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001507092	0.6845841052490486
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001507092	0.6845841052490486
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001507092	0.6845841052490486
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001507092	0.6845841052490486
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001507092	0.6845841052490486
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001507092	0.6845841052490486
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001507092	0.6845841052490486
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.001507092	0.6845841052490486
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.001507092	0.6845841052490486
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001507092	0.6845841052490486
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001507092	0.6845841052490486
KETOADIPICACIDURIA	0.001507092	0.6845841052490486
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.001507092	0.6845841052490486
CK SYNDROME	0.001507092	0.6845841052490486
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001507092	0.6845841052490486
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001507092	0.6845841052490486
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.001507092	0.6845841052490486
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.001507092	0.6845841052490486
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.001507092	0.6845841052490486
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001507092	0.6845841052490486
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001507092	0.6845841052490486
8Q24.3 MICRODELETION SYNDROME	0.001507092	0.6845841052490486
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001507092	0.6845841052490486
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001507092	0.6845841052490486
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001507092	0.6845841052490486
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.001507092	0.6845841052490486
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001507092	0.6845841052490486
GALACTOSE EPIMERASE DEFICIENCY	0.001507092	0.6845841052490486
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001507092	0.6845841052490486
FUMARASE DEFICIENCY; FMRD	0.001507092	0.6845841052490486
STT3B-CDG	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001507092	0.6845841052490486
CHROMOSOME 17P13.1 DELETION SYNDROME	0.001507092	0.6845841052490486
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.001507092	0.6845841052490486
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001507092	0.6845841052490486
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001507092	0.6845841052490486
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.001507092	0.6845841052490486
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001507092	0.6845841052490486
RIGID SPINE SYNDROME	0.001507092	0.6845841052490486
SALT-AND-PEPPER SYNDROME	0.001507092	0.6845841052490486
PRADER-WILLI SYNDROME; PWS	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001507092	0.6845841052490486
SSR4-CDG	0.001507092	0.6845841052490486
STT3A-CDG	0.001507092	0.6845841052490486
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001507092	0.6845841052490486
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.001507092	0.6845841052490486
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.001507092	0.6845841052490486
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001507092	0.6845841052490486
SCHINDLER DISEASE, TYPE I	0.001507092	0.6845841052490486
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001507092	0.6845841052490486
SMITH-MAGENIS SYNDROME; SMS	0.001507092	0.6845841052490486
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.001507092	0.6845841052490486
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.001507092	0.6845841052490486
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001507092	0.6845841052490486
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.001507092	0.6845841052490486
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001507092	0.6845841052490486
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.001507092	0.6845841052490486
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001507092	0.6845841052490486
FOLATE MALABSORPTION, HEREDITARY	0.001507092	0.6845841052490486
POTOCKI-LUPSKI SYNDROME	0.001507092	0.6845841052490486
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001507092	0.6845841052490486
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001507092	0.6845841052490486
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001507092	0.6845841052490486
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.001507092	0.6845841052490486
ADAMS-OLIVER SYNDROME 1; AOS1	0.001507092	0.6845841052490486
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001507092	0.6845841052490486
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001507092	0.6845841052490486
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001507092	0.6845841052490486
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.001507092	0.6845841052490486
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001507092	0.6845841052490486
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001507092	0.6845841052490486
SPINOCEREBELLAR ATAXIA TYPE 29	0.001507092	0.6845841052490486
HOLOPROSENCEPHALY 2; HPE2	0.001507092	0.6845841052490486
WARSAW BREAKAGE SYNDROME; WABS	0.001507092	0.6845841052490486
JOUBERT SYNDROME 6	0.001507092	0.6845841052490486
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.001507092	0.6845841052490486
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.001507092	0.6845841052490486
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.001507092	0.6845841052490486
CHROMOSOME 4Q21 DELETION SYNDROME	0.001507092	0.6845841052490486
SPINOCEREBELLAR ATAXIA TYPE 13	0.001507092	0.6845841052490486
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.001507092	0.6845841052490486
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001507092	0.6845841052490486
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.001507092	0.6845841052490486
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.001507092	0.6845841052490486
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.001507092	0.6845841052490486
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001507092	0.6845841052490486
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.001507092	0.6845841052490486
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.001507092	0.6845841052490486
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.001507092	0.6845841052490486
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001507092	0.6845841052490486
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001507092	0.6845841052490486
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.001507092	0.6845841052490486
CEREBELLAR ATAXIA, CAYMAN TYPE	0.001507092	0.6845841052490486
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001507092	0.6845841052490486
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.001507092	0.6845841052490486
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001507092	0.6845841052490486
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.001507092	0.6845841052490486
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001507092	0.6845841052490486
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.001507092	0.6845841052490486
NIEMANN-PICK DISEASE, TYPE C2	0.001507092	0.6845841052490486
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.001507092	0.6845841052490486
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001507092	0.6845841052490486
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001507092	0.6845841052490486
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.001507092	0.6845841052490486
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001507092	0.6845841052490486
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.001507092	0.6845841052490486
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.001507092	0.6845841052490486
PEROXISOME BIOGENESIS DISORDER 5B	0.001507092	0.6845841052490486
PEROXISOME BIOGENESIS DISORDER 6B	0.001507092	0.6845841052490486
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001507092	0.6845841052490486
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.001507092	0.6845841052490486
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.001507092	0.6845841052490486
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001507092	0.6845841052490486
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001507092	0.6845841052490486
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.001507092	0.6845841052490486
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.001507092	0.6845841052490486
GRISCELLI SYNDROME, TYPE 1	0.001507092	0.6845841052490486
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.001507092	0.6845841052490486
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001507092	0.6845841052490486
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.001507092	0.6845841052490486
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.001507092	0.6845841052490486
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.001507092	0.6845841052490486
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001507092	0.6845841052490486
MICROPHTHALMIA, SYNDROMIC 3	0.001507092	0.6845841052490486
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001507092	0.6845841052490486
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.001507092	0.6845841052490486
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001507092	0.6845841052490486
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001507092	0.6845841052490486
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001507092	0.6845841052490486
JOUBERT SYNDROME 15	0.001507092	0.6845841052490486
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001507092	0.6845841052490486
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001507092	0.6845841052490486
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001507092	0.6845841052490486
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.001507092	0.6845841052490486
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.001507092	0.6845841052490486
PERIPHERAL HYPOTHYROIDISM	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.001507092	0.6845841052490486
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.001507092	0.6845841052490486
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.001507092	0.6845841052490486
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.001507092	0.6845841052490486
COFFIN-SIRIS SYNDROME 2; CSS2	0.001507092	0.6845841052490486
COFFIN-SIRIS SYNDROME 3; CSS3	0.001507092	0.6845841052490486
COFFIN-SIRIS SYNDROME 4; CSS4	0.001507092	0.6845841052490486
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001507092	0.6845841052490486
MUCOLIPIDOSIS IV; ML4	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.001507092	0.6845841052490486
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.001507092	0.6845841052490486
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.001507092	0.6845841052490486
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001507092	0.6845841052490486
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.001507092	0.6845841052490486
WEAVER SYNDROME	0.001507092	0.6845841052490486
JOUBERT SYNDROME 8	0.001507092	0.6845841052490486
JOUBERT SYNDROME 27	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.001507092	0.6845841052490486
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001507092	0.6845841052490486
SPINOCEREBELLAR ATAXIA 5; SCA5	0.001507092	0.6845841052490486
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.001507092	0.6845841052490486
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001507092	0.6845841052490486
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001507092	0.6845841052490486
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.001507092	0.6845841052490486
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001507092	0.6845841052490486
MEHMO SYNDROME; MEHMO	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001507092	0.6845841052490486
YOU-HOOVER-FONG SYNDROME; YHFS	0.001507092	0.6845841052490486
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001507092	0.6845841052490486
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001507092	0.6845841052490486
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.001507092	0.6845841052490486
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.001507092	0.6845841052490486
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.001507092	0.6845841052490486
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.001507092	0.6845841052490486
PEROXISOME BIOGENESIS DISORDER 3B	0.001507092	0.6845841052490486
AICARDI-GOUTIERES SYNDROME 7	0.001507092	0.6845841052490486
OPTIC ATROPHY 11; OPA11	0.001507092	0.6845841052490486
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.001507092	0.6845841052490486
OROFACIODIGITAL SYNDROME TYPE 6	0.001507092	0.6845841052490486
TIMOTHY SYNDROME; TS	0.001507092	0.6845841052490486
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001507092	0.6845841052490486
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001507092	0.6845841052490486
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.001507092	0.6845841052490486
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.001507092	0.6845841052490486
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.001507092	0.6845841052490486
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001507092	0.6845841052490486
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001507092	0.6845841052490486
SULFOCYSTEINURIA	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.001507092	0.6845841052490486
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.001507092	0.6845841052490486
HAREL-YOON SYNDROME; HAYOS	0.001507092	0.6845841052490486
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.001507092	0.6845841052490486
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001507092	0.6845841052490486
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.001507092	0.6845841052490486
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.001507092	0.6845841052490486
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.001507092	0.6845841052490486
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001507092	0.6845841052490486
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.001507092	0.6845841052490486
MENTAL RETARDATION, X-LINKED 99	0.001507092	0.6845841052490486
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001507092	0.6845841052490486
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.001507092	0.6845841052490486
TONNE-KALSCHEUER SYNDROME; TOKAS	0.001507092	0.6845841052490486
XQ25 DUPLICATION SYNDROME	0.001507092	0.6845841052490486
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.001507092	0.6845841052490486
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.001507092	0.6845841052490486
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001507092	0.6845841052490486
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.001507092	0.6845841052490486
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.001507092	0.6845841052490486
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.001507092	0.6845841052490486
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.001507092	0.6845841052490486
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001507092	0.6845841052490486
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.001507092	0.6845841052490486
SHUKLA-VERNON SYNDROME; SHUVER	0.001507092	0.6845841052490486
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001507092	0.6845841052490486
CRANIOFRONTONASAL SYNDROME; CFNS	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001507092	0.6845841052490486
PETTIGREW SYNDROME	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001507092	0.6845841052490486
JOUBERT SYNDROME 24	0.001507092	0.6845841052490486
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001507092	0.6845841052490486
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001507092	0.6845841052490486
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001507092	0.6845841052490486
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001507092	0.6845841052490486
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001507092	0.6845841052490486
LUSCAN-LUMISH SYNDROME; LLS	0.001507092	0.6845841052490486
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.001507092	0.6845841052490486
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001507092	0.6845841052490486
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001507092	0.6845841052490486
PELIZAEUS-MERZBACHER DISEASE	0.001507092	0.6845841052490486
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.001507092	0.6845841052490486
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.001507092	0.6845841052490486
JOUBERT SYNDROME 25	0.001507092	0.6845841052490486
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001507092	0.6845841052490486
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.001507092	0.6845841052490486
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.001507092	0.6845841052490486
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001507092	0.6845841052490486
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.001507092	0.6845841052490486
MENTAL RETARDATION, X-LINKED 41	0.001507092	0.6845841052490486
MENTAL RETARDATION, X-LINKED 90	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.001507092	0.6845841052490486
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001507092	0.6845841052490486
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001507092	0.6845841052490486
DESANTO-SHINAWI SYNDROME	0.001507092	0.6845841052490486
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.001507092	0.6845841052490486
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001507092	0.6845841052490486
PYRUVATE CARBOXYLASE DEFICIENCY	0.001507092	0.6845841052490486
JOUBERT SYNDROME 28	0.001507092	0.6845841052490486
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001507092	0.6845841052490486
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.001507092	0.6845841052490486
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001507092	0.6845841052490486
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.001507092	0.6845841052490486
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.001507092	0.6845841052490486
SHWACHMAN-DIAMOND SYNDROME	0.001507092	0.6845841052490486
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001507092	0.6845841052490486
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001507092	0.6845841052490486
NIEMANN-PICK DISEASE, TYPE A	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.001507092	0.6845841052490486
XQ25 MICRODUPLICATION SYNDROME	0.001507092	0.6845841052490486
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001507092	0.6845841052490486
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001507092	0.6845841052490486
GRISCELLI SYNDROME TYPE 1	0.001507092	0.6845841052490486
NAVAJO NEUROHEPATOPATHY	0.001507092	0.6845841052490486
IMMUNODEFICIENCY 23; IMD23	0.001507092	0.6845841052490486
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001507092	0.6845841052490486
JOUBERT SYNDROME 31; JBTS31	0.001507092	0.6845841052490486
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001507092	0.6845841052490486
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.001507092	0.6845841052490486
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001507092	0.6845841052490486
JOUBERT SYNDROME 32; JBTS32	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001507092	0.6845841052490486
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001507092	0.6845841052490486
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001507092	0.6845841052490486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001507092	0.6845841052490486
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001507092	0.6845841052490486
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.001507092	0.6845841052490486
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001507092	0.6845841052490486
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001507092	0.6845841052490486
EPILEPSY, PYRIDOXINE-DEPENDENT	0.001507092	0.6845841052490486
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001507092	0.6845841052490486
ELEJALDE DISEASE	0.001507092	0.6845841052490486
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001507092	0.6845841052490486
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.001507092	0.6845841052490486
DESBUQUOIS DYSPLASIA 2; DBQD2	0.001507092	0.6845841052490486
PEHO SYNDROME; PEHO	0.001507092	0.6845841052490486
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001507092	0.6845841052490486
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001507092	0.6845841052490486
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001507092	0.6845841052490486
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.0013985999999999998	0.6353025094694413
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.0013985999999999998	0.6353025094694413
OROFACIODIGITAL SYNDROME XVII	0.0013985999999999998	0.6353025094694413
SECKEL SYNDROME 4	0.0013985999999999998	0.6353025094694413
IMAGE SYNDROME	0.0013985999999999998	0.6353025094694413
OROFACIODIGITAL SYNDROME I; OFD1	0.0013985999999999998	0.6353025094694413
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.0013985999999999998	0.6353025094694413
HENNEKAM SYNDROME	0.0013985999999999998	0.6353025094694413
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.0013985999999999998	0.6353025094694413
SLC39A8-CDG	0.0013985999999999998	0.6353025094694413
MEIER-GORLIN SYNDROME 3; MGORS3	0.0013985999999999998	0.6353025094694413
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.0013985999999999998	0.6353025094694413
OROFACIODIGITAL SYNDROME III	0.0013985999999999998	0.6353025094694413
CAMPOMELIC DYSPLASIA	0.0013985999999999998	0.6353025094694413
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.0013985999999999998	0.6353025094694413
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.0013985999999999998	0.6353025094694413
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.0013985999999999998	0.6353025094694413
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.0013985999999999998	0.6353025094694413
ACRORENAL-MANDIBULAR SYNDROME	0.0013985999999999998	0.6353025094694413
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.0013985999999999998	0.6353025094694413
RING CHROMOSOME 10 SYNDROME	0.0013985999999999998	0.6353025094694413
MECKEL SYNDROME, TYPE 1; MKS1	0.0013985999999999998	0.6353025094694413
OROFACIAL CLEFT 15	0.0013985999999999998	0.6353025094694413
MEIER-GORLIN SYNDROME 5; MGORS5	0.0013985999999999998	0.6353025094694413
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.0013985999999999998	0.6353025094694413
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.0013985999999999998	0.6353025094694413
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.0013985999999999998	0.6353025094694413
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.0013985999999999998	0.6353025094694413
CRANIOFACIAL DYSSYNOSTOSIS	0.0013985999999999998	0.6353025094694413
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.0013985999999999998	0.6353025094694413
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.0013985999999999998	0.6353025094694413
TRISOMY 1Q	0.0013985999999999998	0.6353025094694413
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.0013985999999999998	0.6353025094694413
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.0013985999999999998	0.6353025094694413
3Q27.3 MICRODELETION SYNDROME	0.0013985999999999998	0.6353025094694413
HYDROLETHALUS SYNDROME 1	0.0013985999999999998	0.6353025094694413
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.0013985999999999998	0.6353025094694413
HAMAMY SYNDROME; HMMS	0.0013985999999999998	0.6353025094694413
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.0013985999999999998	0.6353025094694413
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.0013985999999999998	0.6353025094694413
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.0013985999999999998	0.6353025094694413
RENAL AGENESIS, BILATERAL	0.0013985999999999998	0.6353025094694413
CONO-SPONDYLAR DYSPLASIA	0.0013985999999999998	0.6353025094694413
INIENCEPHALY	0.0013985999999999998	0.6353025094694413
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0013985999999999998	0.6353025094694413
EDINBURGH MALFORMATION SYNDROME	0.0013985999999999998	0.6353025094694413
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.0013985999999999998	0.6353025094694413
HYPOGLOSSIA WITH SITUS INVERSUS	0.0013985999999999998	0.6353025094694413
PYKNOACHONDROGENESIS	0.0013985999999999998	0.6353025094694413
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.0013985999999999998	0.6353025094694413
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.0013985999999999998	0.6353025094694413
GAPO SYNDROME	0.0013985999999999998	0.6353025094694413
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.0013985999999999998	0.6353025094694413
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.0013985999999999998	0.6353025094694413
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.0013985999999999998	0.6353025094694413
OTOFACIOCERVICAL SYNDROME 2	0.0013985999999999998	0.6353025094694413
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.0013985999999999998	0.6353025094694413
FEMORAL-FACIAL SYNDROME	0.0013985999999999998	0.6353025094694413
15Q26 OVERGROWTH SYNDROME	0.0013985999999999998	0.6353025094694413
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.0013985999999999998	0.6353025094694413
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.0013985999999999998	0.6353025094694413
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.0013985999999999998	0.6353025094694413
ACROCARDIOFACIAL SYNDROME	0.0013985999999999998	0.6353025094694413
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0013985999999999998	0.6353025094694413
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.0013985999999999998	0.6353025094694413
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.0013985999999999998	0.6353025094694413
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.0013985999999999998	0.6353025094694413
PERMANENT NEONATAL DIABETES MELLITUS-PANCREATIC AND CEREBELLAR AGENESIS SYNDROME	0.0013985999999999998	0.6353025094694413
FOCAL DERMAL HYPOPLASIA	0.0013985999999999998	0.6353025094694413
FIBROCHONDROGENESIS	0.0013985999999999998	0.6353025094694413
ATELOSTEOGENESIS TYPE II	0.0013985999999999998	0.6353025094694413
MECKEL SYNDROME 12; MKS12	0.0013985999999999998	0.6353025094694413
MOSAIC TRISOMY 1	0.0013985999999999998	0.6353025094694413
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.0013985999999999998	0.6353025094694413
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.0013985999999999998	0.6353025094694413
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.0013985999999999998	0.6353025094694413
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.0013985999999999998	0.6353025094694413
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0013985999999999998	0.6353025094694413
FOCAL FACIAL DERMAL DYSPLASIA TYPE II	0.0013985999999999998	0.6353025094694413
DIAMOND-BLACKFAN ANEMIA 10	0.0013985999999999998	0.6353025094694413
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.0013985999999999998	0.6353025094694413
SPONDYLO-OCULAR SYNDROME	0.0013985999999999998	0.6353025094694413
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.0013985999999999998	0.6353025094694413
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.0013985999999999998	0.6353025094694413
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.0013985999999999998	0.6353025094694413
GENITOPALATOCARDIAC SYNDROME	0.0013985999999999998	0.6353025094694413
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.0013985999999999998	0.6353025094694413
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.0013985999999999998	0.6353025094694413
KEIPERT SYNDROME; KPTS	0.0013985999999999998	0.6353025094694413
ADNP SYNDROME	0.0013985999999999998	0.6353025094694413
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.0013985999999999998	0.6353025094694413
NEMALINE MYOPATHY 2; NEM2	0.0013985999999999998	0.6353025094694413
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.0013985999999999998	0.6353025094694413
TETRAAMELIA SYNDROME 2; TETAMS2	0.0013985999999999998	0.6353025094694413
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.0013985999999999998	0.6353025094694413
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.0013985999999999998	0.6353025094694413
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.0013985999999999998	0.6353025094694413
KAPUR-TORIELLO SYNDROME	0.0013985999999999998	0.6353025094694413
SCHINZEL-GIEDION SYNDROME	0.0013985999999999998	0.6353025094694413
47,XYY SYNDROME	0.0013985999999999998	0.6353025094694413
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.0013985999999999998	0.6353025094694413
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.0013985999999999998	0.6353025094694413
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.0013985999999999998	0.6353025094694413
THANATOPHORIC DYSPLASIA	0.0013985999999999998	0.6353025094694413
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.0013985999999999998	0.6353025094694413
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.0013985999999999998	0.6353025094694413
TRANSALDOLASE DEFICIENCY	0.0013985999999999998	0.6353025094694413
TEETH, NONERUPTION OF, WITH MAXILLARY HYPOPLASIA AND GENU VALGUM	0.0013985999999999998	0.6353025094694413
SPONDYLOOCULAR SYNDROME; SOS	0.0013985999999999998	0.6353025094694413
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.0013985999999999998	0.6353025094694413
TRICHOHEPATOENTERIC SYNDROME 1	0.0013985999999999998	0.6353025094694413
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.0013985999999999998	0.6353025094694413
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.0013985999999999998	0.6353025094694413
ULBRIGHT-HODES SYNDROME	0.0013985999999999998	0.6353025094694413
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.0013985999999999998	0.6353025094694413
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.0013985999999999998	0.6353025094694413
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.0013985999999999998	0.6353025094694413
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.0013985999999999998	0.6353025094694413
CEREBROOCULONASAL SYNDROME	0.0013985999999999998	0.6353025094694413
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.0013985999999999998	0.6353025094694413
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.0013985999999999998	0.6353025094694413
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.0013985999999999998	0.6353025094694413
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.0013985999999999998	0.6353025094694413
PFEIFFER SYNDROME TYPE 3	0.0013985999999999998	0.6353025094694413
FIBROCHONDROGENESIS 1; FBCG1	0.0013985999999999998	0.6353025094694413
KAPUR-TORIELLO SYNDROME	0.0013985999999999998	0.6353025094694413
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.0013985999999999998	0.6353025094694413
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.0013985999999999998	0.6353025094694413
BARTSOCAS-PAPAS SYNDROME; BPS	0.0013985999999999998	0.6353025094694413
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.0013985999999999998	0.6353025094694413
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.0013985999999999998	0.6353025094694413
OROFACIODIGITAL SYNDROME TYPE 3	0.0013985999999999998	0.6353025094694413
MATTHEW-WOOD SYNDROME	0.0013985999999999998	0.6353025094694413
HALLERMANN-STREIFF SYNDROME; HSS	0.0013985999999999998	0.6353025094694413
AICA-RIBOSIDURIA	0.0013985999999999998	0.6353025094694413
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.0013985999999999998	0.6353025094694413
ROBERTS SYNDROME; RBS	0.0013985999999999998	0.6353025094694413
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.0013985999999999998	0.6353025094694413
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.0013985999999999998	0.6353025094694413
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.0013985999999999998	0.6353025094694413
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.0013985999999999998	0.6353025094694413
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.0013985999999999998	0.6353025094694413
DWARFISM, FAMILIAL, WITH MUSCLE SPASMS	0.0013985999999999998	0.6353025094694413
ECTODERMAL DYSPLASIA SYNDROME	0.0013985999999999998	0.6353025094694413
GENITOPALATOCARDIAC SYNDROME	0.0013985999999999998	0.6353025094694413
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.0013985999999999998	0.6353025094694413
PFEIFFER SYNDROME TYPE 1	0.0013985999999999998	0.6353025094694413
6P22 MICRODELETION SYNDROME	0.0013985999999999998	0.6353025094694413
LOWRY-MACLEAN SYNDROME	0.0013985999999999998	0.6353025094694413
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.0013985999999999998	0.6353025094694413
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0013985999999999998	0.6353025094694413
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.0013985999999999998	0.6353025094694413
STROMME SYNDROME; STROMS	0.0013985999999999998	0.6353025094694413
FGFR2-RELATED BENT BONE DYSPLASIA	0.0013985999999999998	0.6353025094694413
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.0013985999999999998	0.6353025094694413
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.0013985999999999998	0.6353025094694413
COG5-CDG	0.0013985999999999998	0.6353025094694413
BENT BONE DYSPLASIA SYNDROME; BBDS	0.0013985999999999998	0.6353025094694413
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.0013985999999999998	0.6353025094694413
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.0013985999999999998	0.6353025094694413
9P13 MICRODELETION SYNDROME	0.0013985999999999998	0.6353025094694413
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.0013985999999999998	0.6353025094694413
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.0013985999999999998	0.6353025094694413
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.0013985999999999998	0.6353025094694413
ATELOSTEOGENESIS TYPE I	0.0013985999999999998	0.6353025094694413
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.0013985999999999998	0.6353025094694413
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.0013985999999999998	0.6353025094694413
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.0013985999999999998	0.6353025094694413
OROFACIODIGITAL SYNDROME IV; OFD4	0.0013985999999999998	0.6353025094694413
NEU-LAXOVA SYNDROME 2; NLS2	0.0013985999999999998	0.6353025094694413
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.0013985999999999998	0.6353025094694413
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.0013985999999999998	0.6353025094694413
BARBER-SAY SYNDROME; BBRSAY	0.0013985999999999998	0.6353025094694413
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.0013985999999999998	0.6353025094694413
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.0013985999999999998	0.6353025094694413
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0013985999999999998	0.6353025094694413
DISTAL TRISOMY 5Q	0.0013985999999999998	0.6353025094694413
PHAVER SYNDROME	0.0013985999999999998	0.6353025094694413
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.0013985999999999998	0.6353025094694413
FOCAL DERMAL HYPOPLASIA; FDH	0.0013985999999999998	0.6353025094694413
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.0013985999999999998	0.6353025094694413
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0013985999999999998	0.6353025094694413
20P13 MICRODELETION SYNDROME	0.0013985999999999998	0.6353025094694413
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.0013985999999999998	0.6353025094694413
OTOONYCHOPERONEAL SYNDROME	0.0013985999999999998	0.6353025094694413
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.0013985999999999998	0.6353025094694413
ACROOSTEOLYSIS DOMINANT TYPE	0.0013985999999999998	0.6353025094694413
TRISOMY 13	0.0013985999999999998	0.6353025094694413
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.0013985999999999998	0.6353025094694413
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.0013985999999999998	0.6353025094694413
DDOST-CDG	0.0009615380000000001	0.43677070238111526
SPINOCEREBELLAR ATAXIA TYPE 1	0.0009615380000000001	0.43677070238111526
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.0009615380000000001	0.43677070238111526
SYDENHAM CHOREA	0.0009615380000000001	0.43677070238111526
SPINOCEREBELLAR ATAXIA TYPE 2	0.0009615380000000001	0.43677070238111526
MULTIMINICORE MYOPATHY	0.0009615380000000001	0.43677070238111526
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.0009615380000000001	0.43677070238111526
ROIFMAN SYNDROME	0.0009615380000000001	0.43677070238111526
SPINOCEREBELLAR ATAXIA TYPE 10	0.0009615380000000001	0.43677070238111526
7Q11.23 MICRODUPLICATION SYNDROME	0.0009615380000000001	0.43677070238111526
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0009615380000000001	0.43677070238111526
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.0009615380000000001	0.43677070238111526
TEMPLE-BARAITSER SYNDROME	0.0009615380000000001	0.43677070238111526
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.0009615380000000001	0.43677070238111526
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.0009615380000000001	0.43677070238111526
MICROTRIPLICATION 11Q24.1	0.0009615380000000001	0.43677070238111526
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.0009615380000000001	0.43677070238111526
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.0009615380000000001	0.43677070238111526
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.0009615380000000001	0.43677070238111526
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.0009615380000000001	0.43677070238111526
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.0009615380000000001	0.43677070238111526
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.0009615380000000001	0.43677070238111526
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.0009615380000000001	0.43677070238111526
ALG13-CDG	0.0009615380000000001	0.43677070238111526
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0009615380000000001	0.43677070238111526
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.0009615380000000001	0.43677070238111526
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.0009615380000000001	0.43677070238111526
GIANT AXONAL NEUROPATHY	0.0009615380000000001	0.43677070238111526
CLASSIC MULTIMINICORE MYOPATHY	0.0009615380000000001	0.43677070238111526
NEUTRAL LIPID STORAGE MYOPATHY	0.0009615380000000001	0.43677070238111526
COG1-CDG	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.0009615380000000001	0.43677070238111526
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0009615380000000001	0.43677070238111526
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	0.0009615380000000001	0.43677070238111526
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.0009615380000000001	0.43677070238111526
SUSAC SYNDROME	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.0009615380000000001	0.43677070238111526
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.0009615380000000001	0.43677070238111526
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0009615380000000001	0.43677070238111526
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.0009615380000000001	0.43677070238111526
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.0009615380000000001	0.43677070238111526
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.0009615380000000001	0.43677070238111526
RAPID-ONSET DYSTONIA-PARKINSONISM	0.0009615380000000001	0.43677070238111526
ETHYLMALONIC ENCEPHALOPATHY	0.0009615380000000001	0.43677070238111526
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.0009615380000000001	0.43677070238111526
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.0009615380000000001	0.43677070238111526
SPINOCEREBELLAR ATAXIA TYPE 14	0.0009615380000000001	0.43677070238111526
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.0009615380000000001	0.43677070238111526
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0009615380000000001	0.43677070238111526
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.0009615380000000001	0.43677070238111526
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.0009615380000000001	0.43677070238111526
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.0009615380000000001	0.43677070238111526
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0009615380000000001	0.43677070238111526
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0009615380000000001	0.43677070238111526
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, X-LINKED 19	0.0009615380000000001	0.43677070238111526
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.0009615380000000001	0.43677070238111526
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.0009615380000000001	0.43677070238111526
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, X-LINKED 93	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, X-LINKED 12; MRX12	0.0009615380000000001	0.43677070238111526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.0009615380000000001	0.43677070238111526
LESCH-NYHAN SYNDROME; LNS	0.0009615380000000001	0.43677070238111526
CHITAYAT SYNDROME	0.0009615380000000001	0.43677070238111526
ZUNICH NEUROECTODERMAL SYNDROME	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.0009615380000000001	0.43677070238111526
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.0009615380000000001	0.43677070238111526
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, X-LINKED 102	0.0009615380000000001	0.43677070238111526
SUDDEN CARDIAC FAILURE, INFANTILE	0.0009615380000000001	0.43677070238111526
BETHLEM MYOPATHY 2; BTHLM2	0.0009615380000000001	0.43677070238111526
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.0009615380000000001	0.43677070238111526
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.0009615380000000001	0.43677070238111526
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.0009615380000000001	0.43677070238111526
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.0009615380000000001	0.43677070238111526
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, X-LINKED 1	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.0009615380000000001	0.43677070238111526
MENKES DISEASE	0.0009615380000000001	0.43677070238111526
AICARDI SYNDROME; AIC	0.0009615380000000001	0.43677070238111526
COFFIN-LOWRY SYNDROME; CLS	0.0009615380000000001	0.43677070238111526
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.0009615380000000001	0.43677070238111526
SMITH-KINGSMORE SYNDROME; SKS	0.0009615380000000001	0.43677070238111526
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.0009615380000000001	0.43677070238111526
XYLOSIDASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.0009615380000000001	0.43677070238111526
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.0009615380000000001	0.43677070238111526
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.0009615380000000001	0.43677070238111526
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.0009615380000000001	0.43677070238111526
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0009615380000000001	0.43677070238111526
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.0009615380000000001	0.43677070238111526
DESBUQUOIS DYSPLASIA 1	0.0009615380000000001	0.43677070238111526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.0009615380000000001	0.43677070238111526
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.0009615380000000001	0.43677070238111526
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.0009615380000000001	0.43677070238111526
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.0009615380000000001	0.43677070238111526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.0009615380000000001	0.43677070238111526
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0009615380000000001	0.43677070238111526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.0009615380000000001	0.43677070238111526
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.0009615380000000001	0.43677070238111526
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.0009615380000000001	0.43677070238111526
TAY-SACHS DISEASE; TSD	0.0009615380000000001	0.43677070238111526
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.0009615380000000001	0.43677070238111526
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.0009615380000000001	0.43677070238111526
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0009615380000000001	0.43677070238111526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.0009615380000000001	0.43677070238111526
PSEUDO-TORCH SYNDROME 2	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0009615380000000001	0.43677070238111526
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.0009615380000000001	0.43677070238111526
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.0009615380000000001	0.43677070238111526
NEURAMINIDASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
GLYCOGEN STORAGE DISEASE IXB	0.0009615380000000001	0.43677070238111526
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.0009615380000000001	0.43677070238111526
OSTEOPENIA AND SPARSE HAIR	0.0009615380000000001	0.43677070238111526
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.0009615380000000001	0.43677070238111526
OPSISMODYSPLASIA; OPSMD	0.0009615380000000001	0.43677070238111526
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0009615380000000001	0.43677070238111526
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.0009615380000000001	0.43677070238111526
METACHROMATIC LEUKODYSTROPHY	0.0009615380000000001	0.43677070238111526
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.0009615380000000001	0.43677070238111526
COMBINED SAPOSIN DEFICIENCY	0.0009615380000000001	0.43677070238111526
LISSENCEPHALY 3; LIS3	0.0009615380000000001	0.43677070238111526
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.0009615380000000001	0.43677070238111526
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.0009615380000000001	0.43677070238111526
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0009615380000000001	0.43677070238111526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.0009615380000000001	0.43677070238111526
PITT-HOPKINS SYNDROME	0.0009615380000000001	0.43677070238111526
SOTOS SYNDROME 2	0.0009615380000000001	0.43677070238111526
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.0009615380000000001	0.43677070238111526
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.0009615380000000001	0.43677070238111526
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.0009615380000000001	0.43677070238111526
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.0009615380000000001	0.43677070238111526
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.0009615380000000001	0.43677070238111526
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.0009615380000000001	0.43677070238111526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.0009615380000000001	0.43677070238111526
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.0009615380000000001	0.43677070238111526
LIVER FAILURE, INFANTILE, TRANSIENT	0.0009615380000000001	0.43677070238111526
EPILEPSY, HOT WATER, 1	0.0009615380000000001	0.43677070238111526
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.0009615380000000001	0.43677070238111526
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.0009615380000000001	0.43677070238111526
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.0009615380000000001	0.43677070238111526
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.0009615380000000001	0.43677070238111526
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.0009615380000000001	0.43677070238111526
PORPHYRIA, ACUTE HEPATIC	0.0009615380000000001	0.43677070238111526
EPISODIC ATAXIA, TYPE 6	0.0009615380000000001	0.43677070238111526
OSTEOGENESIS IMPERFECTA, TYPE X	0.0009615380000000001	0.43677070238111526
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.0009615380000000001	0.43677070238111526
NEMALINE MYOPATHY 7; NEM7	0.0009615380000000001	0.43677070238111526
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.0009615380000000001	0.43677070238111526
TENORIO SYNDROME; TNORS	0.0009615380000000001	0.43677070238111526
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.0009615380000000001	0.43677070238111526
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.0009615380000000001	0.43677070238111526
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0009615380000000001	0.43677070238111526
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.0009615380000000001	0.43677070238111526
GLYCINE ENCEPHALOPATHY; GCE	0.0009615380000000001	0.43677070238111526
SPINOCEREBELLAR ATAXIA 13	0.0009615380000000001	0.43677070238111526
MYOPATHY, CENTRONUCLEAR, 5	0.0009615380000000001	0.43677070238111526
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.0009615380000000001	0.43677070238111526
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.0009615380000000001	0.43677070238111526
RIGID SPINE MUSCULAR DYSTROPHY 1	0.0009615380000000001	0.43677070238111526
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.0009615380000000001	0.43677070238111526
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.0009615380000000001	0.43677070238111526
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.0009615380000000001	0.43677070238111526
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.0009615380000000001	0.43677070238111526
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.0009615380000000001	0.43677070238111526
PIERSON SYNDROME	0.0009615380000000001	0.43677070238111526
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.0009615380000000001	0.43677070238111526
JOUBERT SYNDROME 4	0.0009615380000000001	0.43677070238111526
PEROXISOME BIOGENESIS DISORDER 11B	0.0009615380000000001	0.43677070238111526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0009615380000000001	0.43677070238111526
KLEEFSTRA SYNDROME	0.0009615380000000001	0.43677070238111526
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.0009615380000000001	0.43677070238111526
JOUBERT SYNDROME 5	0.0009615380000000001	0.43677070238111526
LISSENCEPHALY 5; LIS5	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.0009615380000000001	0.43677070238111526
NEMALINE MYOPATHY 4	0.0009615380000000001	0.43677070238111526
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.0009615380000000001	0.43677070238111526
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.0009615380000000001	0.43677070238111526
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.0009615380000000001	0.43677070238111526
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.0009615380000000001	0.43677070238111526
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.0009615380000000001	0.43677070238111526
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.0009615380000000001	0.43677070238111526
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0009615380000000001	0.43677070238111526
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.0009615380000000001	0.43677070238111526
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.0009615380000000001	0.43677070238111526
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.0009615380000000001	0.43677070238111526
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.0009615380000000001	0.43677070238111526
ADDUCTED THUMBS SYNDROME	0.0009615380000000001	0.43677070238111526
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
LYSINURIC PROTEIN INTOLERANCE; LPI	0.0009615380000000001	0.43677070238111526
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.0009615380000000001	0.43677070238111526
CHIARI MALFORMATION TYPE II	0.0009615380000000001	0.43677070238111526
HYPERCALCEMIA, INFANTILE, 1	0.0009615380000000001	0.43677070238111526
ASPARTYLGLUCOSAMINURIA; AGU	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.0009615380000000001	0.43677070238111526
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.0009615380000000001	0.43677070238111526
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0009615380000000001	0.43677070238111526
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.0009615380000000001	0.43677070238111526
ZIMMERMANN-LABAND SYNDROME 1	0.0009615380000000001	0.43677070238111526
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0009615380000000001	0.43677070238111526
CAP MYOPATHY	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.0009615380000000001	0.43677070238111526
COHEN SYNDROME	0.0009615380000000001	0.43677070238111526
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0009615380000000001	0.43677070238111526
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.0009615380000000001	0.43677070238111526
GLYCOGEN STORAGE DISEASE IV	0.0009615380000000001	0.43677070238111526
GLYCOGEN STORAGE DISEASE II	0.0009615380000000001	0.43677070238111526
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.0009615380000000001	0.43677070238111526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0009615380000000001	0.43677070238111526
ETHANOLAMINOSIS	0.0009615380000000001	0.43677070238111526
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0009615380000000001	0.43677070238111526
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.0009615380000000001	0.43677070238111526
SPINOCEREBELLAR ATAXIA 2; SCA2	0.0009615380000000001	0.43677070238111526
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.0009615380000000001	0.43677070238111526
SHPRINTZEN OMPHALOCELE SYNDROME	0.0009615380000000001	0.43677070238111526
VISCERAL STEATOSIS, CONGENITAL	0.0009615380000000001	0.43677070238111526
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0009615380000000001	0.43677070238111526
HUNTINGTON DISEASE-LIKE 1	0.0009615380000000001	0.43677070238111526
EHLERS-DANLOS SYNDROME, TYPE VI	0.0009615380000000001	0.43677070238111526
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.0009615380000000001	0.43677070238111526
ACID PHOSPHATASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.0009615380000000001	0.43677070238111526
SPINOCEREBELLAR ATAXIA 1	0.0009615380000000001	0.43677070238111526
MYOTONIC DYSTROPHY 1	0.0009615380000000001	0.43677070238111526
GLUTARIC ACIDEMIA I; GA1	0.0009615380000000001	0.43677070238111526
DYSTONIA 11, MYOCLONIC	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.0009615380000000001	0.43677070238111526
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.0009615380000000001	0.43677070238111526
CEREBELLAR HYPOPLASIA	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.0009615380000000001	0.43677070238111526
MAPLE SYRUP URINE DISEASE; MSUD	0.0009615380000000001	0.43677070238111526
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0009615380000000001	0.43677070238111526
JOHANSON-BLIZZARD SYNDROME; JBS	0.0009615380000000001	0.43677070238111526
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0009615380000000001	0.43677070238111526
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0009615380000000001	0.43677070238111526
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.0009615380000000001	0.43677070238111526
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.0009615380000000001	0.43677070238111526
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.0009615380000000001	0.43677070238111526
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.0009615380000000001	0.43677070238111526
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.0009615380000000001	0.43677070238111526
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.0009615380000000001	0.43677070238111526
HYPOPHOSPHATASIA, INFANTILE	0.0009615380000000001	0.43677070238111526
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.0009615380000000001	0.43677070238111526
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.0009615380000000001	0.43677070238111526
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.0009615380000000001	0.43677070238111526
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000545554	0.24781340286793335
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000545554	0.24781340286793335
AUSTRALIA ANTIGEN	0.000545554	0.24781340286793335
BARDET-BIEDL SYNDROME 1; BBS1	0.000545554	0.24781340286793335
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.24781340286793335
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.24781340286793335
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.24781340286793335
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.24781340286793335
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.24781340286793335
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.24781340286793335
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.000545554	0.24781340286793335
THYROID HYPOPLASIA	0.000545554	0.24781340286793335
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.000545554	0.24781340286793335
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.24781340286793335
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.000545554	0.24781340286793335
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.000545554	0.24781340286793335
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.24781340286793335
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.24781340286793335
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000545554	0.24781340286793335
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000545554	0.24781340286793335
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000545554	0.24781340286793335
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.000545554	0.24781340286793335
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.24781340286793335
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.24781340286793335
TRANSKETOLASE DEFICIENCY	0.000545554	0.24781340286793335
KRABBE DISEASE	0.000545554	0.24781340286793335
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000545554	0.24781340286793335
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.24781340286793335
DISTAL MONOSOMY 19P13.3	0.000545554	0.24781340286793335
LISSENCEPHALY 1; LIS1	0.000545554	0.24781340286793335
PROPIONIC ACIDEMIA	0.000545554	0.24781340286793335
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.24781340286793335
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.24781340286793335
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000545554	0.24781340286793335
HURLER SYNDROME	0.000545554	0.24781340286793335
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000545554	0.24781340286793335
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.24781340286793335
LIG4 SYNDROME	0.000545554	0.24781340286793335
PHACE ASSOCIATION	0.000545554	0.24781340286793335
16P13.2 MICRODELETION SYNDROME	0.000545554	0.24781340286793335
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.000545554	0.24781340286793335
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.24781340286793335
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000545554	0.24781340286793335
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.24781340286793335
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000545554	0.24781340286793335
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.24781340286793335
ARGININOSUCCINIC ACIDURIA	0.000545554	0.24781340286793335
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000545554	0.24781340286793335
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.000545554	0.24781340286793335
ALSTROM SYNDROME; ALMS	0.000545554	0.24781340286793335
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.24781340286793335
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.000545554	0.24781340286793335
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.000545554	0.24781340286793335
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.24781340286793335
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.24781340286793335
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.24781340286793335
MYOCLONIC EPILEPSY OF INFANCY	0.000545554	0.24781340286793335
PELGER-HUET ANOMALY; PHA	0.000545554	0.24781340286793335
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.24781340286793335
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.24781340286793335
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000545554	0.24781340286793335
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.24781340286793335
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.24781340286793335
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000545554	0.24781340286793335
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.24781340286793335
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.000545554	0.24781340286793335
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.24781340286793335
COG2-CDG	0.000545554	0.24781340286793335
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.24781340286793335
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000545554	0.24781340286793335
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.24781340286793335
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.24781340286793335
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.24781340286793335
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.24781340286793335
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.24781340286793335
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.24781340286793335
CONGENITAL HYPOTHYROIDISM	0.000545554	0.24781340286793335
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000545554	0.24781340286793335
48,XYYY SYNDROME	0.000545554	0.24781340286793335
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.24781340286793335
RIDDLE SYNDROME	0.000545554	0.24781340286793335
XQ28 (MECP2) DUPLICATION	0.000545554	0.24781340286793335
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.24781340286793335
TRANSIENT NEONATAL DIABETES MELLITUS	0.000545554	0.24781340286793335
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.000545554	0.24781340286793335
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.24781340286793335
ISOLATED GLYCEROL KINASE DEFICIENCY	0.000545554	0.24781340286793335
PERMANENT NEONATAL DIABETES MELLITUS	0.000545554	0.24781340286793335
15Q13.3 MICRODELETION SYNDROME	0.000545554	0.24781340286793335
12Q14 MICRODELETION SYNDROME	0.000545554	0.24781340286793335
8P23.1 DUPLICATION SYNDROME	0.000545554	0.24781340286793335
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.24781340286793335
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000545554	0.24781340286793335
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000545554	0.24781340286793335
DYSTONIA-APHONIA SYNDROME	0.000545554	0.24781340286793335
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.24781340286793335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000545554	0.24781340286793335
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000545554	0.24781340286793335
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000545554	0.24781340286793335
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.24781340286793335
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.24781340286793335
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.000545554	0.24781340286793335
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.000545554	0.24781340286793335
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000545554	0.24781340286793335
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.24781340286793335
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.000545554	0.24781340286793335
CHROMOSOME 16P13.3 DELETION SYNDROME	0.000545554	0.24781340286793335
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.24781340286793335
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000545554	0.24781340286793335
ZEBRA BODY MYOPATHY	0.000545554	0.24781340286793335
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.24781340286793335
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.24781340286793335
CURRARINO SYNDROME	0.000545554	0.24781340286793335
INCONTINENTIA PIGMENTI	0.000545554	0.24781340286793335
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.000545554	0.24781340286793335
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.24781340286793335
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.24781340286793335
SEPTOOPTIC DYSPLASIA	0.000545554	0.24781340286793335
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000545554	0.24781340286793335
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.000545554	0.24781340286793335
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.24781340286793335
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.24781340286793335
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000545554	0.24781340286793335
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.24781340286793335
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.24781340286793335
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.24781340286793335
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.24781340286793335
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.000545554	0.24781340286793335
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.000545554	0.24781340286793335
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.000545554	0.24781340286793335
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.24781340286793335
KBG SYNDROME	0.000545554	0.24781340286793335
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.24781340286793335
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.24781340286793335
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.24781340286793335
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.24781340286793335
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000545554	0.24781340286793335
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.24781340286793335
PALLISTER-HALL SYNDROME	0.000545554	0.24781340286793335
MAPLE SYRUP URINE DISEASE	0.000545554	0.24781340286793335
ATHYREOSIS	0.000545554	0.24781340286793335
PIERPONT SYNDROME	0.000545554	0.24781340286793335
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.000545554	0.24781340286793335
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.000545554	0.24781340286793335
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.000545554	0.24781340286793335
PMM2-CDG	0.000545554	0.24781340286793335
ALG6-CDG	0.000545554	0.24781340286793335
ALG3-CDG	0.000545554	0.24781340286793335
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.24781340286793335
HYDROXYKYNURENINURIA	0.000545554	0.24781340286793335
ALG1-CDG	0.000545554	0.24781340286793335
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.24781340286793335
GAUCHER DISEASE, TYPE II	0.000545554	0.24781340286793335
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.24781340286793335
HEREDITARY FOLATE MALABSORPTION	0.000545554	0.24781340286793335
REVESZ SYNDROME	0.000545554	0.24781340286793335
ARGININEMIA	0.000545554	0.24781340286793335
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.24781340286793335
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.24781340286793335
TETRASOMY X	0.000545554	0.24781340286793335
SCHIZENCEPHALY	0.000545554	0.24781340286793335
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.000545554	0.24781340286793335
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000545554	0.24781340286793335
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.000545554	0.24781340286793335
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.000545554	0.24781340286793335
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.24781340286793335
300270 ADRENOMYODYSTROPHY	0.000545554	0.24781340286793335
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.000545554	0.24781340286793335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000545554	0.24781340286793335
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000545554	0.24781340286793335
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.24781340286793335
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000545554	0.24781340286793335
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.24781340286793335
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000545554	0.24781340286793335
WAARDENBURG-SHAH SYNDROME	0.000545554	0.24781340286793335
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.24781340286793335
HYDROXYKYNURENINURIA	0.000545554	0.24781340286793335
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.24781340286793335
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.24781340286793335
HARTNUP DISORDER	0.000545554	0.24781340286793335
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.24781340286793335
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.24781340286793335
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000545554	0.24781340286793335
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000545554	0.24781340286793335
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000545554	0.24781340286793335
LANDAU-KLEFFNER SYNDROME	0.000545554	0.24781340286793335
MACDERMOT-WINTER SYNDROME	0.000545554	0.24781340286793335
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.24781340286793335
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.24781340286793335
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.24781340286793335
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000545554	0.24781340286793335
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000545554	0.24781340286793335
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.24781340286793335
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.24781340286793335
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000545554	0.24781340286793335
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000545554	0.24781340286793335
JAWAD SYNDROME	0.000545554	0.24781340286793335
FRIED SYNDROME	0.000545554	0.24781340286793335
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.24781340286793335
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.24781340286793335
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.000545554	0.24781340286793335
TREACHER-COLLINS SYNDROME	0.000545554	0.24781340286793335
DPAGT1-CDG	0.000545554	0.24781340286793335
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.000545554	0.24781340286793335
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.000545554	0.24781340286793335
PELLAGRA-LIKE SYNDROME	0.000545554	0.24781340286793335
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.24781340286793335
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.24781340286793335
SMITH-MAGENIS SYNDROME	0.000545554	0.24781340286793335
FREE SIALIC ACID STORAGE DISEASE	0.000545554	0.24781340286793335
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.24781340286793335
OROTIC ACIDURIA	0.000545554	0.24781340286793335
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.24781340286793335
SYNDROMIC DIARRHEA	0.000545554	0.24781340286793335
TAY-SACHS DISEASE	0.000545554	0.24781340286793335
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.24781340286793335
LISSENCEPHALY 2; LIS2	0.000545554	0.24781340286793335
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.24781340286793335
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000545554	0.24781340286793335
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.24781340286793335
NETHERTON SYNDROME; NETH	0.000545554	0.24781340286793335
KEUTEL SYNDROME	0.000545554	0.24781340286793335
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000545554	0.24781340286793335
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.24781340286793335
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.24781340286793335
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.000545554	0.24781340286793335
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000545554	0.24781340286793335
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.24781340286793335
WAISMAN SYNDROME; WSMN	0.000545554	0.24781340286793335
MARINESCO-SJÖGREN SYNDROME	0.000545554	0.24781340286793335
CITRULLINEMIA, CLASSIC	0.000545554	0.24781340286793335
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000545554	0.24781340286793335
ATELOSTEOGENESIS TYPE III	0.000545554	0.24781340286793335
MENTAL RETARDATION, X-LINKED 9	0.000545554	0.24781340286793335
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.24781340286793335
MUCOPOLYSACCHARIDOSIS TYPE 2	0.000545554	0.24781340286793335
MULTIPLE SULFATASE DEFICIENCY	0.000545554	0.24781340286793335
INFANTILE REFSUM DISEASE	0.000545554	0.24781340286793335
15Q24 MICRODELETION SYNDROME	0.000545554	0.24781340286793335
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.000545554	0.24781340286793335
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.24781340286793335
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.24781340286793335
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.24781340286793335
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.24781340286793335
ALPHA-MANNOSIDOSIS	0.000545554	0.24781340286793335
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.24781340286793335
PITUITARY STALK INTERRUPTION SYNDROME	0.000545554	0.24781340286793335
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.24781340286793335
CRANIOPHARYNGIOMA	0.000545554	0.24781340286793335
WYBURN-MASON SYNDROME	0.000545554	0.24781340286793335
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.24781340286793335
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.000545554	0.24781340286793335
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.000545554	0.24781340286793335
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.24781340286793335
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.24781340286793335
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.24781340286793335
BAND HETEROTOPIA; BH	0.000545554	0.24781340286793335
LOWRY-MACLEAN SYNDROME	0.000545554	0.24781340286793335
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.000545554	0.24781340286793335
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.24781340286793335
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.000545554	0.24781340286793335
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.24781340286793335
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000545554	0.24781340286793335
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.000545554	0.24781340286793335
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.24781340286793335
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000545554	0.24781340286793335
THYROID ECTOPIA	0.000545554	0.24781340286793335
MEDULLOBLASTOMA	0.000545554	0.24781340286793335
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000545554	0.24781340286793335
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000545554	0.24781340286793335
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.24781340286793335
BARATELA-SCOTT SYNDROME	0.000545554	0.24781340286793335
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.24781340286793335
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000545554	0.24781340286793335
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.24781340286793335
MENTAL RETARDATION, X-LINKED 88	0.000545554	0.24781340286793335
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.24781340286793335
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.000545554	0.24781340286793335
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.24781340286793335
ALPERS-HUTTENLOCHER SYNDROME	0.000545554	0.24781340286793335
BETA-UREIDOPROPIONASE DEFICIENCY	0.000545554	0.24781340286793335
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000545554	0.24781340286793335
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.24781340286793335
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.24781340286793335
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000545554	0.24781340286793335
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000545554	0.24781340286793335
PYRUVATE DEHYDROGENASE DEFICIENCY	0.000545554	0.24781340286793335
RABSON-MENDENHALL SYNDROME	0.000545554	0.24781340286793335
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.000545554	0.24781340286793335
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000545554	0.24781340286793335
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.000545554	0.24781340286793335
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.000545554	0.24781340286793335
HURLER SYNDROME	0.000545554	0.24781340286793335
NETHERTON SYNDROME	0.000545554	0.24781340286793335
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000545554	0.24781340286793335
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.24781340286793335
ALSTRÖM SYNDROME	0.000545554	0.24781340286793335
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.24781340286793335
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000545554	0.24781340286793335
NARP SYNDROME	0.000545554	0.24781340286793335
NIEMANN-PICK DISEASE TYPE C	0.000545554	0.24781340286793335
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.24781340286793335
LEBER CONGENITAL AMAUROSIS	0.000545554	0.24781340286793335
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000545554	0.24781340286793335
MENTAL RETARDATION, X-LINKED 103	0.000545554	0.24781340286793335
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.24781340286793335
CEDNIK SYNDROME	0.000545554	0.24781340286793335
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.24781340286793335
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.000545554	0.24781340286793335
COWDEN SYNDROME	0.000545554	0.24781340286793335
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.000545554	0.24781340286793335
GABA-TRANSAMINASE DEFICIENCY	0.000545554	0.24781340286793335
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.000545554	0.24781340286793335
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000545554	0.24781340286793335
CHROMOSOME 1P35 DELETION SYNDROME	0.000545554	0.24781340286793335
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.000545554	0.24781340286793335
MIETENS SYNDROME	0.000545554	0.24781340286793335
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.000545554	0.24781340286793335
N SYNDROME	0.000545554	0.24781340286793335
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.000545554	0.24781340286793335
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.000545554	0.24781340286793335
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.000545554	0.24781340286793335
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.24781340286793335
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.24781340286793335
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.000545554	0.24781340286793335
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000545554	0.24781340286793335
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000545554	0.24781340286793335
DISTAL 16P11.2 MICRODELETION SYNDROME	0.000545554	0.24781340286793335
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.24781340286793335
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.24781340286793335
17Q12 MICRODELETION SYNDROME	0.000545554	0.24781340286793335
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.24781340286793335
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.24781340286793335
20P12.3 MICRODELETION SYNDROME	0.000545554	0.24781340286793335
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.24781340286793335
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.24781340286793335
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.000545554	0.24781340286793335
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.000545554	0.24781340286793335
HYPEREKPLEXIA 4; HKPX4	0.000545554	0.24781340286793335
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.000545554	0.24781340286793335
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000545554	0.24781340286793335
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.24781340286793335
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.24781340286793335
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000545554	0.24781340286793335
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.000545554	0.24781340286793335
1Q21.1 MICRODELETION SYNDROME	0.000545554	0.24781340286793335
1Q21.1 MICRODUPLICATION SYNDROME	0.000545554	0.24781340286793335
MICRO SYNDROME	0.000545554	0.24781340286793335
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000545554	0.24781340286793335
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.24781340286793335
6Q25 MICRODELETION SYNDROME	0.000545554	0.24781340286793335
BAKER-GORDON SYNDROME; BAGOS	0.000545554	0.24781340286793335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000545554	0.24781340286793335
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.24781340286793335
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000545554	0.24781340286793335
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.000545554	0.24781340286793335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000545554	0.24781340286793335
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000545554	0.24781340286793335
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.24781340286793335
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000545554	0.24781340286793335
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000545554	0.24781340286793335
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.24781340286793335
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.24781340286793335
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.24781340286793335
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000545554	0.24781340286793335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000545554	0.24781340286793335
ROIFMAN-CHITAYAT SYNDROME	0.000545554	0.24781340286793335
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.000545554	0.24781340286793335
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000545554	0.24781340286793335
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.24781340286793335
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.24781340286793335
L1 SYNDROME	0.000545554	0.24781340286793335
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.24781340286793335
LISSENCEPHALY 8; LIS8	0.000545554	0.24781340286793335
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.24781340286793335
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000545554	0.24781340286793335
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.000545554	0.24781340286793335
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.000545554	0.24781340286793335
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.000545554	0.24781340286793335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.000545554	0.24781340286793335
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.24781340286793335
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.24781340286793335
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.24781340286793335
POTOCKI-SHAFFER SYNDROME	0.000545554	0.24781340286793335
OTOFACIOCERVICAL SYNDROME	0.000545554	0.24781340286793335
ALAZAMI-YUAN SYNDROME	0.000545554	0.24781340286793335
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.24781340286793335
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.24781340286793335
ALG11-CDG	0.000545554	0.24781340286793335
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.24781340286793335
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000545554	0.24781340286793335
W SYNDROME	0.000545554	0.24781340286793335
OROFACIODIGITAL SYNDROME TYPE 2	0.000545554	0.24781340286793335
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.24781340286793335
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.000545554	0.24781340286793335
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.24781340286793335
KLEEFSTRA SYNDROME	0.000545554	0.24781340286793335
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.000545554	0.24781340286793335
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.24781340286793335
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.24781340286793335
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.24781340286793335
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.24781340286793335
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.000545554	0.24781340286793335
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000545554	0.24781340286793335
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.24781340286793335
MECKEL SYNDROME 13; MKS13	0.000545554	0.24781340286793335
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000545554	0.24781340286793335
RAHMAN SYNDROME	0.000545554	0.24781340286793335
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000545554	0.24781340286793335
PEHO-LIKE SYNDROME; PEHOL	0.000545554	0.24781340286793335
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.24781340286793335
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.000545554	0.24781340286793335
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.24781340286793335
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.24781340286793335
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000545554	0.24781340286793335
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.24781340286793335
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.000545554	0.24781340286793335
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.000545554	0.24781340286793335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.000545554	0.24781340286793335
CITRULLINEMIA TYPE II	0.000545554	0.24781340286793335
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.24781340286793335
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.24781340286793335
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.24781340286793335
DONNAI-BARROW SYNDROME	0.000545554	0.24781340286793335
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.24781340286793335
1P36 DELETION SYNDROME	0.000545554	0.24781340286793335
MONOSOMY 18Q	0.000545554	0.24781340286793335
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000545554	0.24781340286793335
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000545554	0.24781340286793335
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.24781340286793335
17Q21.31 MICRODUPLICATION SYNDROME	0.000545554	0.24781340286793335
HYDRANENCEPHALY	0.000545554	0.24781340286793335
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.24781340286793335
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.000545554	0.24781340286793335
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.24781340286793335
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000545554	0.24781340286793335
VICI SYNDROME	0.000545554	0.24781340286793335
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.24781340286793335
MATERNAL PHENYLKETONURIA	0.000545554	0.24781340286793335
MULTIPLE CARBOXYLASE DEFICIENCY	0.000545554	0.24781340286793335
XQ21 MICRODELETION SYNDROME	0.000545554	0.24781340286793335
CANAVAN DISEASE	0.000545554	0.24781340286793335
17Q11.2 MICRODUPLICATION SYNDROME	0.000545554	0.24781340286793335
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.24781340286793335
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.000545554	0.24781340286793335
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.24781340286793335
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000545554	0.24781340286793335
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000545554	0.24781340286793335
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.000545554	0.24781340286793335
DISTAL MONOSOMY 9P	0.000545554	0.24781340286793335
DEXTROCARDIA	0.000545554	0.24781340286793335
FLOATING-HARBOR SYNDROME	0.000545554	0.24781340286793335
FOIX-CHAVANY-MARIE SYNDROME	0.000545554	0.24781340286793335
COLE-CARPENTER SYNDROME	0.000545554	0.24781340286793335
EAST SYNDROME	0.000545554	0.24781340286793335
OCCIPITAL HORN SYNDROME	0.000545554	0.24781340286793335
MYOCLONIC-ASTASTIC EPILEPSY	0.000545554	0.24781340286793335
EARLY MYOCLONIC ENCEPHALOPATHY	0.000545554	0.24781340286793335
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.000545554	0.24781340286793335
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.24781340286793335
COHEN SYNDROME	0.000545554	0.24781340286793335
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.24781340286793335
DYSKERATOSIS CONGENITA	0.000545554	0.24781340286793335
GERMAN SYNDROME	0.000545554	0.24781340286793335
GERODERMA OSTEODYSPLASTICA	0.000545554	0.24781340286793335
TRISOMY 8Q	0.000545554	0.24781340286793335
DISTAL TRISOMY 18Q	0.000545554	0.24781340286793335
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.000545554	0.24781340286793335
17P11.2 MICRODUPLICATION SYNDROME	0.000545554	0.24781340286793335
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.000545554	0.24781340286793335
BRAIN-LUNG-THYROID SYNDROME	0.000545554	0.24781340286793335
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.000545554	0.24781340286793335
HARTNUP DISEASE	0.000545554	0.24781340286793335
CHÉDIAK-HIGASHI SYNDROME	0.000545554	0.24781340286793335
NEPHROGENIC DIABETES INSIPIDUS	0.000545554	0.24781340286793335
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000545554	0.24781340286793335
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.24781340286793335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.000545554	0.24781340286793335
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000545554	0.24781340286793335
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.000545554	0.24781340286793335
KBG SYNDROME	0.000545554	0.24781340286793335
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000545554	0.24781340286793335
TRISOMY 9P	0.000545554	0.24781340286793335
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.24781340286793335
15Q11Q13 MICRODUPLICATION SYNDROME	0.000545554	0.24781340286793335
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.24781340286793335
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.24781340286793335
1Q44 MICRODELETION SYNDROME	0.000545554	0.24781340286793335
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.24781340286793335
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000545554	0.24781340286793335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000545554	0.24781340286793335
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000545554	0.24781340286793335
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.24781340286793335
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.24781340286793335
RFT1-CDG	0.000545554	0.24781340286793335
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000545554	0.24781340286793335
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.24781340286793335
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.24781340286793335
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000545554	0.24781340286793335
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.24781340286793335
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000545554	0.24781340286793335
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000545554	0.24781340286793335
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000545554	0.24781340286793335
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.24781340286793335
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.24781340286793335
CONGENITAL DISORDER OF GLYCOSYLATION	0.000545554	0.24781340286793335
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.24781340286793335
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.24781340286793335
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.24781340286793335
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.24781340286793335
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.24781340286793335
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.24781340286793335
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.24781340286793335
PENTASOMY X	0.000545554	0.24781340286793335
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.24781340286793335
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.24781340286793335
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.000545554	0.24781340286793335
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.000545554	0.24781340286793335
TRANSALDOLASE DEFICIENCY	0.000545554	0.24781340286793335
8Q12 MICRODUPLICATION SYNDROME	0.000545554	0.24781340286793335
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.24781340286793335
2Q37 MICRODELETION SYNDROME	0.000545554	0.24781340286793335
MICROVILLUS INCLUSION DISEASE	0.000545554	0.24781340286793335
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000545554	0.24781340286793335
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.24781340286793335
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.000545554	0.24781340286793335
USHER SYNDROME TYPE 1	0.000545554	0.24781340286793335
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.000545554	0.24781340286793335
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.24781340286793335
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.000545554	0.24781340286793335
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000545554	0.24781340286793335
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.24781340286793335
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000545554	0.24781340286793335
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.24781340286793335
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000545554	0.24781340286793335
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000545554	0.24781340286793335
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.24781340286793335
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.24781340286793335
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.24781340286793335
STEEL SYNDROME; STLS	0.000545554	0.24781340286793335
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.24781340286793335
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.24781340286793335
WEAVER SYNDROME	0.000545554	0.24781340286793335
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000545554	0.24781340286793335
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.24781340286793335
WILSON-TURNER SYNDROME	0.000545554	0.24781340286793335
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.24781340286793335
FUCOSIDOSIS	0.000545554	0.24781340286793335
PROPIONIC ACIDEMIA	0.000545554	0.24781340286793335
ISOLATED PLAGIOCEPHALY	0.000545554	0.24781340286793335
EPIDERMAL NEVUS SYNDROME	0.000545554	0.24781340286793335
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.24781340286793335
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.24781340286793335
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.24781340286793335
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.000545554	0.24781340286793335
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.000545554	0.24781340286793335
TRISOMY X	0.000545554	0.24781340286793335
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.24781340286793335
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.24781340286793335
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.24781340286793335
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.24781340286793335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.24781340286793335
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.000545554	0.24781340286793335
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.24781340286793335
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.24781340286793335
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.24781340286793335
ABETAL34V AMYLOIDOSIS	0.000545554	0.24781340286793335
SRD5A3-CDG	0.000545554	0.24781340286793335
FILIPPI SYNDROME	0.000545554	0.24781340286793335
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.24781340286793335
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000545554	0.24781340286793335
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.24781340286793335
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000545554	0.24781340286793335
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.000545554	0.24781340286793335
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.000545554	0.24781340286793335
ISOVALERIC ACIDEMIA	0.000545554	0.24781340286793335
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.24781340286793335
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000545554	0.24781340286793335
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000545554	0.24781340286793335
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.24781340286793335
FARBER DISEASE	0.000545554	0.24781340286793335
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.24781340286793335
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000545554	0.24781340286793335
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.000545554	0.24781340286793335
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.24781340286793335
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.24781340286793335
LISSENCEPHALY 4	0.000545554	0.24781340286793335
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.000545554	0.24781340286793335
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.000545554	0.24781340286793335
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.24781340286793335
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.000545554	0.24781340286793335
SIMPSON-GOLABI-BEHMEL SYNDROME	0.000545554	0.24781340286793335
GRISCELLI SYNDROME	0.000545554	0.24781340286793335
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.24781340286793335
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000545554	0.24781340286793335
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.000545554	0.24781340286793335
HSD10 DISEASE	0.000545554	0.24781340286793335
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.24781340286793335
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.000545554	0.24781340286793335
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.24781340286793335
CHROMOSOME 19P13.13 DELETION SYNDROME	0.000545554	0.24781340286793335
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.000545554	0.24781340286793335
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.000545554	0.24781340286793335
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.24781340286793335
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.24781340286793335
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.24781340286793335
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.24781340286793335
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.24781340286793335
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.24781340286793335
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.24781340286793335
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.24781340286793335
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000545554	0.24781340286793335
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.24781340286793335
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.000545554	0.24781340286793335
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000545554	0.24781340286793335
SLC35A2-CDG	0.000545554	0.24781340286793335
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000545554	0.24781340286793335
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.000545554	0.24781340286793335
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.000545554	0.24781340286793335
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.24781340286793335
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.24781340286793335
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.24781340286793335
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.24781340286793335
HOLOPROSENCEPHALY 11	0.000545554	0.24781340286793335
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000545554	0.24781340286793335
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.24781340286793335
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000545554	0.24781340286793335
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.000545554	0.24781340286793335
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.24781340286793335
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.24781340286793335
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000545554	0.24781340286793335
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.24781340286793335
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000545554	0.24781340286793335
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.000545554	0.24781340286793335
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000545554	0.24781340286793335
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.24781340286793335
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.24781340286793335
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.24781340286793335
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000545554	0.24781340286793335
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000545554	0.24781340286793335
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.24781340286793335
CONGENITAL VARICELLA SYNDROME	0.000545554	0.24781340286793335
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.24781340286793335
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.24781340286793335
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.000545554	0.24781340286793335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.000545554	0.24781340286793335
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.24781340286793335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000545554	0.24781340286793335
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.000545554	0.24781340286793335
1P21.3 MICRODELETION SYNDROME	0.000545554	0.24781340286793335
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.000545554	0.24781340286793335
SENIOR-LOKEN SYNDROME 9	0.000545554	0.24781340286793335
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.000545554	0.24781340286793335
SECKEL SYNDROME 8; SCKL8	0.000545554	0.24781340286793335
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.24781340286793335
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.000545554	0.24781340286793335
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.24781340286793335
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.24781340286793335
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.24781340286793335
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.24781340286793335
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000545554	0.24781340286793335
HEREDITARY OROTIC ACIDURIA	0.000545554	0.24781340286793335
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000545554	0.24781340286793335
11P15.4 MICRODUPLICATION SYNDROME	0.000545554	0.24781340286793335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000545554	0.24781340286793335
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000545554	0.24781340286793335
MEVALONIC ACIDURIA	0.000545554	0.24781340286793335
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.24781340286793335
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.24781340286793335
MEIER-GORLIN SYNDROME 7	0.000545554	0.24781340286793335
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.24781340286793335
PEHO SYNDROME	0.000545554	0.24781340286793335
MIRAGE SYNDROME; MIRAGE	0.000545554	0.24781340286793335
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.000545554	0.24781340286793335
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.24781340286793335
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000545554	0.24781340286793335
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.24781340286793335
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000545554	0.24781340286793335
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.24781340286793335
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.24781340286793335
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.24781340286793335
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000545554	0.24781340286793335
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.24781340286793335
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.24781340286793335
EVEN-PLUS SYNDROME	0.000545554	0.24781340286793335
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.24781340286793335
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.24781340286793335
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.24781340286793335
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.000545554	0.24781340286793335
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.24781340286793335
SECKEL SYNDROME 9; SCKL9	0.000545554	0.24781340286793335
PITT-HOPKINS SYNDROME	0.000545554	0.24781340286793335
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000545554	0.24781340286793335
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.000545554	0.24781340286793335
PYRIDOXINE-DEPENDENT EPILEPSY	0.000545554	0.24781340286793335
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.24781340286793335
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.24781340286793335
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.24781340286793335
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.000545554	0.24781340286793335
BARDET-BIEDL SYNDROME 2	0.000545554	0.24781340286793335
SEVERE CANAVAN DISEASE	0.000545554	0.24781340286793335
SENIOR-LOKEN SYNDROME	0.000545554	0.24781340286793335
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.000545554	0.24781340286793335
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.24781340286793335
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.24781340286793335
WEBB-DATTANI SYNDROME; WEDAS	0.000545554	0.24781340286793335
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.24781340286793335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000545554	0.24781340286793335
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000545554	0.24781340286793335
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000545554	0.24781340286793335
CULLER-JONES SYNDROME; CJS	0.000545554	0.24781340286793335
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.24781340286793335
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.24781340286793335
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.24781340286793335
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.24781340286793335
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000545554	0.24781340286793335
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.24781340286793335
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000545554	0.24781340286793335
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.24781340286793335
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.24781340286793335
2Q23.1 MICRODUPLICATION SYNDROME	0.000545554	0.24781340286793335
CHOPS SYNDROME; CHOPS	0.000545554	0.24781340286793335
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.24781340286793335
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.24781340286793335
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.24781340286793335
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000545554	0.24781340286793335
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.24781340286793335
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.000545554	0.24781340286793335
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.24781340286793335
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000545554	0.24781340286793335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000545554	0.24781340286793335
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.24781340286793335
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000545554	0.24781340286793335
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000545554	0.24781340286793335
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.24781340286793335
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.24781340286793335
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.24781340286793335
OXOGLUTARIC ACIDURIA	0.000545554	0.24781340286793335
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.24781340286793335
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000545554	0.24781340286793335
SARCOSINEMIA	0.000545554	0.24781340286793335
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000545554	0.24781340286793335
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.24781340286793335
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.000545554	0.24781340286793335
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.24781340286793335
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.24781340286793335
SOTOS SYNDROME	0.000545554	0.24781340286793335
